Matricaria	matricaria	JJ	O
chamomilla	chamomilla	NN	O
L.	L.	NNP	O
i.e.	i.e.	FW	O
chamomile	chamomile	NNP	O
,	,	,	O
native	native	JJ	O
to	to	IN	O
southern	southern	JJ	O
and	and	CC	O
eastern	eastern	JJ	O
Europe	Europe	NNP	O
and	and	CC	O
widely	widely	RB	O
found	find	VBN	O
in	in	IN	O
Brazil	Brazil	NNP	O
,	,	,	O
is	be	VBZ	O
one	one	CD	O
of	of	IN	O
the	the	DT	O
oldest	old	JJS	O
known	known	JJ	O
herbs	herb	NNS	O
of	of	IN	O
traditional	traditional	JJ	O
medicine	medicine	NN	O
and	and	CC	O
belongs	belong	VBZ	O
to	to	IN	O
the	the	DT	O
Asteraceae	Asteraceae	NNP	O
family	family	NN	O
.	.	.	O

It	-PRON-	PRP	O
contains	contain	VBZ	O
a	a	DT	O
large	large	JJ	O
group	group	NN	O
of	of	IN	O
therapeutically	therapeutically	RB	O
interesting	interesting	JJ	O
and	and	CC	O
active	active	JJ	O
compounds	compound	NNS	O
,	,	,	O
the	the	DT	O
main	main	JJ	O
classes	class	NNS	O
being	be	VBG	O
the	the	DT	O
flavonoids	flavonoid	NNS	O
,	,	,	O
sesquiterpenes	sesquiterpene	NNS	O
,	,	,	O
coumarins	coumarin	NNS	O
,	,	,	O
and	and	CC	O
polyacetylenes	polyacetylene	VBZ	B
.	.	.	O

The	the	DT	O
flowers	flower	NNS	O
in	in	IN	O
particular	particular	JJ	O
,	,	,	O
contain	contain	VBP	O
a	a	DT	O
large	large	JJ	O
amount	amount	NN	O
of	of	IN	O
hydrophilic	hydrophilic	JJ	O
constituents	constituent	NNS	O
sugars	sugar	NNS	O
,	,	,	O
flavonoids	flavonoid	NNS	O
,	,	,	O
mucilages	mucilage	NNS	O
,	,	,	O
phenyl	phenyl	NNP	O
carbonic	carbonic	JJ	O
acids	acid	NNS	O
,	,	,	O
amino	amino	JJ	O
acids	acid	NNS	O
,	,	,	O
choline	choline	NN	O
,	,	,	O
salts	salt	NNS	O
)	)	-RRB-	B
.	.	.	O

Flavonoids	flavonoid	NNS	O
such	such	JJ	O
as	as	IN	O
apigenin-7-O	apigenin-7-o	NN	O
-	-	HYPH	O
glucoside	glucoside	NN	O
,	,	,	O
apigenin	apigenin	JJ	O
,	,	,	O
luteolin-7-O	luteolin-7-o	NN	O
-	-	HYPH	O
glucoside	glucoside	NN	O
and	and	CC	O
luteolin	luteolin	NN	O
flavones	flavone	NNS	O
,	,	,	O
rutin	rutin	NN	O
and	and	CC	O
quercetin	quercetin	NNP	O
flavonols	flavonol	NNS	O
and	and	CC	O
many	many	JJ	O
other	other	JJ	O
phenolic	phenolic	JJ	O
compounds	compound	NNS	O
such	such	JJ	O
as	as	IN	O
herniarin	herniarin	NNP	O
and	and	CC	O
umbelliferone	umbelliferone	NNP	O
coumarin	coumarin	NNP	O
,	,	,	O
chlorogenic	chlorogenic	JJ	O
acid	acid	NN	O
,	,	,	O
and	and	CC	O
caffeic	caffeic	NN	O
acid	acid	NN	O
phenylpropanoids	phenylpropanoid	NNS	O
are	be	VBP	O
found	find	VBN	O
in	in	IN	O
chamomile	chamomile	NN	O
extract	extract	NN	B
.	.	.	O

Among	among	IN	O
those	those	DT	O
,	,	,	O
apigenin	apigenin	JJ	O
and	and	CC	O
esculin	esculin	NNP	O
are	be	VBP	O
the	the	DT	O
most	most	RBS	O
promising	promising	JJ	O
compounds	compound	NNS	O
with	with	IN	O
respect	respect	NN	O
to	to	IN	O
human	human	JJ	O
health	health	NN	O
.	.	.	O

They	-PRON-	PRP	O
are	be	VBP	O
present	present	JJ	O
in	in	IN	O
very	very	RB	O
small	small	JJ	O
quantities	quantity	NNS	O
as	as	IN	O
free	free	JJ	O
apigenin	apigenin	NN	O
and	and	CC	O
esculetin	esculetin	NN	O
,	,	,	O
respectively	respectively	RB	O
,	,	,	O
but	but	CC	O
predominantly	predominantly	RB	O
exist	exist	VBP	O
in	in	IN	O
the	the	DT	O
form	form	NN	O
of	of	IN	O
various	various	JJ	O
glycosides	glycoside	NNS	B
.	.	.	O

Polyphenols	polyphenol	NNS	O
are	be	VBP	O
secondary	secondary	JJ	O
metabolites	metabolite	NNS	O
affected	affect	VBN	O
by	by	IN	O
environmental	environmental	JJ	O
and	and	CC	O
seasonal	seasonal	JJ	O
conditions	condition	NNS	O
and	and	CC	O
by	by	IN	O
the	the	DT	O
geographic	geographic	JJ	O
origin	origin	NN	O
of	of	IN	O
plants	plant	NNS	O
.	.	.	O

In	in	IN	O
that	that	DT	O
light	light	NN	O
,	,	,	O
a	a	DT	O
diverse	diverse	JJ	O
polyphenolic	polyphenolic	JJ	O
fingerprint	fingerprint	NN	O
characterises	characterise	VBZ	O
the	the	DT	O
Matricaria	Matricaria	NNP	O
chamomilla	chamomilla	NN	O
L.	L.	NNP	O
plant	plant	NN	O
and	and	CC	O
,	,	,	O
evidently	evidently	RB	O
,	,	,	O
its	-PRON-	PRP$	O
biological	biological	JJ	O
activity	activity	NN	O
too	too	RB	O
.	.	.	O

Chamomile	Chamomile	NNP	O
is	be	VBZ	O
used	use	VBN	O
mainly	mainly	RB	O
as	as	IN	O
an	an	DT	O
anti	anti	JJ	O
-	-	JJ	O
inflammatory	inflammatory	JJ	O
and	and	CC	O
antiseptic	antiseptic	JJ	O
,	,	,	O
but	but	CC	O
also	also	RB	O
has	have	VBZ	O
anticonvulsant	anticonvulsant	NN	O
,	,	,	O
antispasmodic	antispasmodic	JJ	O
,	,	,	O
and	and	CC	O
analgesic	analgesic	JJ	O
properties	property	NNS	O
.	.	.	O

In	in	IN	O
vitro	vitro	FW	O
and	and	CC	O
inÂ	inâ	JJ	O
vivo	vivo	NN	O
studies	study	NNS	O
have	have	VBP	O
found	find	VBN	O
that	that	IN	O
M.	M.	NNP	O
chamomilla	chamomilla	NNP	O
L.	L.	NNP	O
exhibits	exhibit	VBZ	O
antifungal	antifungal	JJ	O
,	,	,	O
antihypertensive	antihypertensive	JJ	O
,	,	,	O
antiallergic	antiallergic	NNP	O
,	,	,	O
hypoglycaemic	hypoglycaemic	NNP	O
,	,	,	O
analgesic	analgesic	JJ	O
,	,	,	O
immunomodulatory	immunomodulatory	JJ	O
,	,	,	O
antiulcerogenic	antiulcerogenic	JJ	O
,	,	,	O
hepatoprotective	hepatoprotective	JJ	O
,	,	,	O
chemopreventive	chemopreventive	JJ	O
,	,	,	O
and	and	CC	O
anticancer	anticancer	NN	O
properties	property	NNS	B
.	.	.	O

Chamomile	chamomile	NN	O
may	may	MD	O
also	also	RB	O
have	have	VB	O
sedative	sedative	JJ	O
and	and	CC	O
anxiolytic	anxiolytic	JJ	O
effects	effect	NNS	O
because	because	IN	O
of	of	IN	O
apigeninâs	apigeninâs	CD	O
ability	ability	NN	O
to	to	TO	O
bind	bind	VB	O
to	to	IN	O
benzodiazepine	benzodiazepine	NN	O
receptors	receptor	NNS	O
potentiating	potentiate	VBG	O
the	the	DT	O
activity	activity	NN	O
at	at	IN	O
GABA	GABA	NNP	O
A	A	NNP	O
receptors	receptor	NNS	B
.	.	.	O

Natural	natural	JJ	O
flavonoids	flavonoid	NNS	O
,	,	,	O
predominantly	predominantly	RB	O
found	find	VBN	O
in	in	IN	O
their	-PRON-	PRP$	O
glycosylated	glycosylate	VBN	O
form	form	NN	O
,	,	,	O
are	be	VBP	O
widely	widely	RB	O
known	know	VBN	O
for	for	IN	O
their	-PRON-	PRP$	O
antioxidant	antioxidant	JJ	O
potential	potential	JJ	B
,	,	,	B
and	and	CC	O
as	as	IN	O
digestive	digestive	JJ	O
enzyme	enzyme	NNS	O
inhibitors	inhibitor	VBZ	B
.	.	.	O

Their	-PRON-	PRP$	O
antioxidant	antioxidant	JJ	O
activity	activity	NN	O
depends	depend	VBZ	O
on	on	IN	O
the	the	DT	O
position	position	NN	O
and	and	CC	O
structure	structure	NN	O
of	of	IN	O
the	the	DT	O
sugar(s	sugar(s	NN	O
in	in	IN	O
the	the	DT	O
flavonoid	flavonoid	NN	O
molecule	molecule	NN	O
and	and	CC	O
usually	usually	RB	O
decreases	decrease	VBZ	O
with	with	IN	O
the	the	DT	O
increase	increase	NN	O
in	in	IN	O
the	the	DT	O
number	number	NN	O
of	of	IN	O
glycosidic	glycosidic	JJ	O
moieties	moiety	NNS	O
linked	link	VBN	O
to	to	IN	O
a	a	DT	O
hydrophobic	hydrophobic	JJ	O
aglycone	aglycone	NN	O
.	.	.	O

Glycosylated	glycosylate	VBN	O
flavonoids	flavonoid	NNS	O
generally	generally	RB	O
display	display	VBP	O
lower	low	JJR	O
antioxidant	antioxidant	JJ	O
capacity	capacity	NN	O
compared	compare	VBN	O
to	to	IN	O
the	the	DT	O
corresponding	correspond	VBG	O
aglycones	aglycone	NNS	B
,	,	,	B
,	,	,	B
.	.	.	O

The	the	DT	O
hydrolysis	hydrolysis	NN	O
of	of	IN	O
the	the	DT	O
glycosidic	glycosidic	JJ	O
fractions	fraction	NNS	O
of	of	IN	O
various	various	JJ	O
natural	natural	JJ	O
flavonoids	flavonoid	NNS	O
employing	employ	VBG	O
specific	specific	JJ	O
enzymes	enzyme	NNS	O
is	be	VBZ	O
an	an	DT	O
excellent	excellent	JJ	O
way	way	NN	O
to	to	TO	O
modify	modify	VB	O
the	the	DT	O
structure	structure	NN	O
and	and	CC	O
improve	improve	VB	O
the	the	DT	O
physicochemical	physicochemical	JJ	O
and	and	CC	O
biological	biological	JJ	O
properties	property	NNS	O
of	of	IN	O
flavonoids	flavonoid	NNS	B
.	.	.	O

Previous	previous	JJ	O
reports	report	NNS	O
have	have	VBP	O
shown	show	VBN	O
that	that	IN	O
the	the	DT	O
hydrolysis	hydrolysis	NN	O
of	of	IN	O
specific	specific	JJ	O
glycosyl	glycosyl	JJ	O
groups	group	NNS	O
of	of	IN	O
glycosylated	glycosylate	VBN	O
flavonoids	flavonoid	NNS	O
increases	increase	VBZ	O
the	the	DT	O
antioxidant	antioxidant	JJ	O
and	and	CC	O
antiproliferative	antiproliferative	JJ	O
activities	activity	NNS	O
of	of	IN	O
rutin	rutin	NN	B
and	and	CC	O
increases	increase	VBZ	O
the	the	DT	O
antioxidant	antioxidant	JJ	O
activity	activity	NN	O
of	of	IN	O
kaempferol	kaempferol	NNP	B
,	,	,	O
besides	besides	IN	O
improving	improve	VBG	O
the	the	DT	O
anti	anti	JJ	O
-	-	JJ	O
inflammatory	inflammatory	JJ	O
activity	activity	NN	O
of	of	IN	O
naringin	naringin	NN	B
.	.	.	O

The	the	DT	O
use	use	NN	O
of	of	IN	O
enzymes	enzyme	NNS	O
has	have	VBZ	O
been	be	VBN	O
of	of	IN	O
great	great	RB	O
scientific	scientific	JJ	O
and	and	CC	O
industrial	industrial	JJ	O
interest	interest	NN	O
due	due	IN	O
to	to	IN	O
their	-PRON-	PRP$	O
wide	wide	JJ	O
availability	availability	NN	O
,	,	,	O
high	high	JJ	O
selectivity	selectivity	NN	O
and	and	CC	O
their	-PRON-	PRP$	O
promotion	promotion	NN	O
of	of	IN	O
efficient	efficient	JJ	O
reactions	reaction	NNS	O
with	with	IN	O
few	few	JJ	O
by	by	NNS	O
-	-	HYPH	O
products	product	NNS	O
.	.	.	O

Commercial	commercial	JJ	O
hesperidinase	hesperidinase	NN	O
and	and	CC	O
Î²-galactosidase	Î²-galactosidase	NNS	O
are	be	VBP	O
widely	widely	RB	O
employed	employ	VBN	O
in	in	IN	O
biotechnological	biotechnological	JJ	O
deglycosylation	deglycosylation	NN	O
processes	process	NNS	O
producing	produce	VBG	O
the	the	DT	O
respective	respective	JJ	O
partially	partially	RB	O
deglycosylated	deglycosylate	VBN	O
flavonoids	flavonoid	NNS	O
or	or	CC	O
aglycones	aglycone	NNS	O
.	.	.	O

Hesperidinase	Hesperidinase	NNP	O
is	be	VBZ	O
a	a	DT	O
fungal	fungal	JJ	O
enzyme	enzyme	NNS	O
that	that	WDT	O
expresses	express	VBZ	O
both	both	DT	O
Î±-l	Î±-l	NNP	O
-	-	HYPH	O
rhamnosidase	rhamnosidase	NNP	O
EC	EC	NNP	O
3.2.1.40	3.2.1.40	CD	O
and	and	CC	O
Î²-d	Î²-d	NNP	O
-	-	HYPH	O
glucosidase	glucosidase	NNP	O
3.2.1.21	3.2.1.21	CD	O
activities	activity	NNS	O
resulting	result	VBG	O
in	in	IN	O
rhamnose	rhamnose	NN	O
and	and	CC	O
glucose	glucose	VBP	O
release	release	NN	O
,	,	,	O
respectively	respectively	RB	O
,	,	,	O
from	from	IN	O
a	a	DT	O
variety	variety	NN	O
of	of	IN	O
conjugated	conjugate	VBN	O
flavonoids	flavonoid	NNS	B
.	.	.	O

Î²-galactosidase	Î²-galactosidase	NNP	O
can	can	MD	O
be	be	VB	O
obtained	obtain	VBN	O
in	in	IN	O
large	large	JJ	O
quantities	quantity	NNS	O
from	from	IN	O
a	a	DT	O
special	special	JJ	O
strain	strain	NN	O
of	of	IN	O
Aspergillus	Aspergillus	NNP	O
oryzae	oryzae	NNS	O
and	and	CC	O
exhibits	exhibit	VBZ	O
a	a	DT	O
strong	strong	JJ	O
linkage	linkage	NN	O
specificity	specificity	NN	O
for	for	IN	O
Î²	Î²	NNP	O
1â4	1â4	NNP	O
linkages	linkage	NNS	O
galactosyl	galactosyl	NN	O
residues	residue	VBZ	B
.	.	.	O

Previous	previous	JJ	O
results	result	NNS	O
have	have	VBP	O
shown	show	VBN	O
the	the	DT	O
feasibility	feasibility	NN	O
of	of	IN	O
producing	produce	VBG	O
highly	highly	RB	O
purified	purify	VBN	O
kaempferol	kaempferol	NN	O
from	from	IN	O
two	two	CD	O
kaempferol	kaempferol	NN	O
glycosides	glycoside	NNS	O
by	by	IN	O
enzymatic	enzymatic	JJ	O
hydrolysis	hydrolysis	NN	O
using	use	VBG	O
the	the	DT	O
optimum	optimum	JJ	O
combination	combination	NN	O
of	of	IN	O
the	the	DT	O
enzymes	enzyme	NNS	O
hesperidinase	hesperidinase	NN	O
and	and	CC	O
Î²-galactosidase	Î²-galactosidase	NNP	B
.	.	.	O

The	the	DT	O
combination	combination	NN	O
of	of	IN	O
these	these	DT	O
two	two	CD	O
enzymes	enzyme	NNS	O
may	may	MD	O
account	account	VB	O
for	for	IN	O
a	a	DT	O
significant	significant	JJ	O
metabolic	metabolic	JJ	O
change	change	NN	O
in	in	IN	O
plant	plant	NN	O
extracts	extract	VBZ	O
rich	rich	JJ	O
in	in	IN	O
conjugated	conjugate	VBN	O
flavonoids	flavonoid	NNS	O
such	such	JJ	O
as	as	IN	O
chamomile	chamomile	NN	O
infusion	infusion	NN	O
.	.	.	O

In	in	IN	O
the	the	DT	O
present	present	JJ	O
work	work	NN	O
,	,	,	O
the	the	DT	O
enzymatic	enzymatic	JJ	O
hydrolysis	hydrolysis	NN	O
of	of	IN	O
an	an	DT	O
aqueous	aqueous	JJ	O
infusion	infusion	NN	O
of	of	IN	O
Matricaria	Matricaria	NNP	O
chamomilla	chamomilla	NN	O
L.	L.	NNP	O
was	be	VBD	O
carried	carry	VBN	O
out	out	RP	O
using	use	VBG	O
the	the	DT	O
combination	combination	NN	O
of	of	IN	O
these	these	DT	O
enzymes	enzyme	NNS	O
hesperidinase	hesperidinase	NN	O
and	and	CC	O
Î²-galactosidase	Î²-galactosidase	NNP	O
and	and	CC	O
subsequently	subsequently	RB	O
the	the	DT	O
metabolite	metabolite	JJ	O
profile	profile	NN	O
,	,	,	O
the	the	DT	O
antioxidant	antioxidant	JJ	O
activity	activity	NN	O
and	and	CC	O
the	the	DT	O
inhibitory	inhibitory	JJ	O
effect	effect	NN	O
on	on	IN	O
digestive	digestive	JJ	O
enzymes	enzyme	NNS	O
of	of	IN	O
native	native	JJ	O
and	and	CC	O
enzymatically	enzymatically	RB	O
modified	modify	VBN	O
infusions	infusion	NNS	O
were	be	VBD	O
evaluated	evaluate	VBN	O
.	.	.	O

To	to	TO	O
elucidate	elucidate	VB	O
the	the	DT	O
discriminating	discriminate	VBG	O
metabolic	metabolic	JJ	O
profile	profile	NN	O
after	after	IN	O
the	the	DT	O
enzymatic	enzymatic	JJ	O
hydrolysis	hydrolysis	NN	O
of	of	IN	O
the	the	DT	O
chamomile	chamomile	NN	O
infusion	infusion	NN	O
,	,	,	O
an	an	DT	O
untargeted	untargeted	JJ	O
metabolomics	metabolomic	NNS	B
approach	approach	NN	O
based	base	VBN	O
on	on	IN	O
UPLC	UPLC	NNP	O
-	-	HYPH	O
QTOF	QTOF	NNP	O
-	-	HYPH	O
MSE	MSE	NNP	O
was	be	VBD	O
performed	perform	VBN	O
.	.	.	O

This	this	DT	O
high	high	JJ	O
resolution	resolution	NN	O
platform	platform	NN	O
integrates	integrate	VBZ	O
full	full	JJ	O
MS	MS	NNP	O
with	with	IN	O
MS	MS	NNP	O
/	/	SYM	O
MS	MS	NNP	O
fragmentation	fragmentation	NN	O
for	for	IN	O
all	all	DT	O
precursor	precursor	NN	O
ions	ion	NNS	O
simultaneously	simultaneously	RB	B
,	,	,	O
allowing	allow	VBG	O
high	high	JJ	O
-	-	HYPH	O
throughput	throughput	NN	O
acquisition	acquisition	NN	O
of	of	IN	O
data	datum	NNS	O
and	and	CC	O
simultaneous	simultaneous	JJ	O
annotation	annotation	NN	O
of	of	IN	O
diverse	diverse	JJ	O
groups	group	NNS	O
of	of	IN	O
secondary	secondary	JJ	O
metabolites	metabolite	NNS	O
.	.	.	O

Hesperidinase	Hesperidinase	NNP	O
Hesperidin	Hesperidin	NNP	O
-	-	HYPH	O
Î±-1,6-rhamnosidase	Î±-1,6-rhamnosidase	NNP	O
from	from	IN	O
Penicillium	Penicillium	NNP	O
sp	sp	NNP	O
.	.	NNP	O

,	,	,	O
Î²-galactosidase	Î²-galactosidase	NNP	O
from	from	IN	O
Aspergillus	Aspergillus	NNP	O
oryzae	oryzae	NNS	O
,	,	,	O
lipase	lipase	VBP	O
from	from	IN	O
porcine	porcine	NN	O
pancreas	pancrea	NNS	O
type	type	NN	O
II	II	NNP	O
,	,	,	O
Î±-amylase	Î±-amylase	NNP	O
from	from	IN	O
Bacillus	bacillus	NN	O
subtilis	subtili	NNS	O
,	,	,	O
Î±-glucosidase	î±-glucosidase	VBP	O
from	from	IN	O
Bacillus	bacillus	JJ	O
stearothermophilus	stearothermophilus	NN	O
,	,	,	O
DPPHâ¢	DPPHâ¢	NNP	O
2,2-diphenyl-1-picril	2,2-diphenyl-1-picril	CD	O
-	-	HYPH	O
hydrozyl	hydrozyl	NN	O
radical	radical	NN	O
,	,	,	O
nitrophenyl	nitrophenyl	NN	O
-	-	HYPH	O
Î±-D	î±-d	NN	O
-	-	HYPH	O
glucopyranoside	glucopyranoside	NNP	O
,	,	,	O
and	and	CC	O
p	p	NN	O
-	-	HYPH	O
nitrophenyl	nitrophenyl	NN	O
palmitate	palmitate	NN	O
were	be	VBD	O
purchased	purchase	VBN	O
from	from	IN	O
Sigma	Sigma	NNP	O
-	-	HYPH	O
Aldrich	Aldrich	NNP	O
St.	St.	NNP	O
Louis	Louis	NNP	O
,	,	,	O
MO	MO	NNP	O
.	.	.	O

The	the	DT	O
infusion	infusion	NN	O
was	be	VBD	O
prepared	prepare	VBN	O
by	by	IN	O
crushing	crush	VBG	O
dried	dry	VBN	O
plant	plant	NN	O
material	material	NN	O
purchased	purchase	VBN	O
from	from	IN	O
a	a	DT	O
local	local	JJ	O
market	market	NN	O
in	in	IN	O
the	the	DT	O
city	city	NN	O
of	of	IN	O
BraganÃ§a	BraganÃ§a	NNP	O
Paulista	Paulista	NNP	O
,	,	,	O
Brazil	Brazil	NNP	O
.	.	.	O

A	a	DT	O
sample	sample	NN	O
of	of	IN	O
plant	plant	NN	O
material	material	NN	O
was	be	VBD	O
accurately	accurately	RB	O
weighed	weigh	VBN	O
,	,	,	O
added	add	VBN	O
to	to	IN	O
boiling	boil	VBG	O
distilled	distil	VBN	O
water	water	NN	O
at	at	IN	O
a	a	DT	O
1:10	1:10	CD	O
w	w	NN	O
/	/	SYM	O
v	v	NN	O
sample	sample	NN	O
to	to	TO	O
solvent	solvent	NN	O
ratio	ratio	NN	O
in	in	IN	O
a	a	DT	O
stainless	stainless	JJ	O
steel	steel	NN	O
pot	pot	NN	O
and	and	CC	O
left	leave	VBD	O
at	at	IN	O
25âÂ	25ââ	CD	O
°	°	,	O
C	C	NNP	O
for	for	IN	O
15âmin	15âmin	NNP	O
,	,	,	O
then	then	RB	O
filtered	filter	VBN	O
under	under	IN	O
reduced	reduce	VBN	O
pressure	pressure	NN	O
.	.	.	O

Prior	prior	RB	O
to	to	IN	O
analysis	analysis	NN	O
,	,	,	O
the	the	DT	O
extraction	extraction	NN	O
solution	solution	NN	O
was	be	VBD	O
filtered	filter	VBN	O
thought	think	VBN	O
a	a	DT	O
0.20âÂµm	0.20âÂµm	NNP	O
nylon	nylon	NN	O
membrane	membrane	NN	O
filter	filter	NN	O
into	into	IN	O
a	a	DT	O
HPLC	hplc	NN	O
vial	vial	NN	O
.	.	.	O

The	the	DT	O
bioconversion	bioconversion	NN	O
reaction	reaction	NN	O
was	be	VBD	O
carried	carry	VBN	O
out	out	RP	O
in	in	IN	O
screw	screw	NN	O
-	-	HYPH	O
capped	cap	VBN	O
glass	glass	NN	O
tubes	tube	NNS	O
with	with	IN	O
shaking	shake	VBG	O
130ârpm	130ârpm	CD	O
at	at	IN	O
controlled	control	VBN	O
temperature	temperature	NN	O
40âÂ	40ââ	CD	O
°	°	,	O
C	C	NNP	O
for	for	IN	O
8âh	8âh	CD	O
using	use	VBG	O
10âml	10âml	CD	O
of	of	IN	O
aqueous	aqueous	JJ	O
infusion	infusion	NN	O
of	of	IN	O
Matricaria	Matricaria	NNP	O
chamomilla	chamomilla	NN	O
.	.	.	O

To	to	TO	O
initiate	initiate	VB	O
the	the	DT	O
hydrolysis	hydrolysis	NN	O
of	of	IN	O
the	the	DT	O
flavonoid	flavonoid	JJ	O
glycosides	glycoside	NNS	O
,	,	,	O
1âml	1âml	CD	O
of	of	IN	O
enzyme	enzyme	NNS	O
mixture	mixture	NN	O
solution	solution	NN	O
prepared	prepare	VBN	O
in	in	IN	O
0.1âM	0.1âm	CD	O
acetate	acetate	JJ	O
buffer	buffer	NN	O
pH	pH	NNP	O
4.0	4.0	CD	O
was	be	VBD	O
added	add	VBN	O
to	to	IN	O
the	the	DT	O
reaction	reaction	NN	O
mixture	mixture	NN	O
.	.	.	O

The	the	DT	O
enzyme	enzyme	NNS	O
mixture	mixture	NN	O
used	use	VBN	O
had	have	VBD	O
equal	equal	JJ	O
parts	part	NNS	O
of	of	IN	O
each	each	DT	O
up	up	RP	O
hesperidinase	hesperidinase	NN	O
and	and	CC	O
Î²-galactosidase	Î²-galactosidase	NNP	O
to	to	IN	O
a	a	DT	O
final	final	JJ	O
concentration	concentration	NN	O
of	of	IN	O
0.02âmg	0.02âmg	NNP	O
/	/	SYM	O
mL.	mL.	NNP	O
Optimisation	Optimisation	NNP	O
of	of	IN	O
hydrolysis	hydrolysis	NN	O
conditions	condition	NNS	O
and	and	CC	O
incubation	incubation	NN	O
time	time	NN	O
using	use	VBG	O
the	the	DT	O
enzyme	enzyme	NNS	O
combination	combination	NN	O
was	be	VBD	O
previously	previously	RB	O
performed	perform	VBN	B
.	.	.	O

The	the	DT	O
reactions	reaction	NNS	O
were	be	VBD	O
stopped	stop	VBN	O
by	by	IN	O
boiling	boil	VBG	O
for	for	IN	O
20âmin	20âmin	CD	O
and	and	CC	O
the	the	DT	O
samples	sample	NNS	O
were	be	VBD	O
stored	store	VBN	O
in	in	IN	O
a	a	DT	O
refrigerator	refrigerator	NN	O
to	to	TO	O
await	await	VB	O
analysis	analysis	NN	O
.	.	.	O

The	the	DT	O
assays	assay	NNS	O
were	be	VBD	O
performed	perform	VBN	O
in	in	IN	O
triplicate	triplicate	NN	O
.	.	.	O

According	accord	VBG	O
to	to	IN	O
the	the	DT	O
manufacturerâs	manufacturerâs	CD	O
information	information	NN	O
,	,	,	O
hesperidinase	hesperidinase	NN	O
expresses	express	VBZ	O
both	both	DT	O
Î±-l	Î±-l	NNP	O
-	-	HYPH	O
rhamnosidase	rhamnosidase	NNP	O
EC	EC	NNP	O
3.2.1.40	3.2.1.40	CD	O
and	and	CC	O
Î²-d	Î²-d	NNP	O
-	-	HYPH	O
glucosidase	glucosidase	NNP	O
3.2.1.21	3.2.1.21	CD	O
activities	activity	NNS	O
.	.	.	O

One	one	CD	O
unit	unit	NN	O
will	will	MD	O
liberate	liberate	VB	O
1.0	1.0	CD	O
Âµmole	Âµmole	NNP	O
of	of	IN	O
reducing	reduce	VBG	O
sugar	sugar	NN	O
as	as	IN	O
glucose	glucose	NN	O
from	from	IN	O
hesperidin	hesperidin	NNP	O
per	per	IN	O
min	min	NN	O
at	at	IN	O
pH	pH	NNP	O
3.8	3.8	CD	O
,	,	,	O
at	at	IN	O
40âÂ	40ââ	CD	O
°	°	NNS	O
C	C	NNP	O
.	.	.	O

For	for	IN	O
Î²-galactosidase	î²-galactosidase	JJ	O
activity	activity	NN	O
,	,	,	O
one	one	CD	O
unit	unit	NN	O
will	will	MD	O
hydrolyse	hydrolyse	VB	O
1.0	1.0	CD	O
Âµmole	âµmole	NN	O
of	of	IN	O
lactose	lactose	NN	O
per	per	IN	O
minute	minute	NN	O
at	at	IN	O
pH	pH	NNP	O
4.5	4.5	CD	O
,	,	,	O
at	at	IN	O
30âÂ	30âÂ	NNP	O
°	°	,	O
C	C	NNP	O
.	.	.	O

The	the	DT	O
analytical	analytical	JJ	O
LC	LC	NNP	O
/	/	SYM	O
MS	MS	NNP	O
experiments	experiment	NNS	O
were	be	VBD	O
performed	perform	VBN	O
on	on	IN	O
an	an	DT	O
ACQUITY	ACQUITY	NNP	O
FTN	FTN	NNP	O
liquid	liquid	JJ	O
chromatograph	chromatograph	NN	O
coupled	couple	VBN	O
to	to	IN	O
a	a	DT	O
XEVO	XEVO	NNP	O
-	-	HYPH	O
G2XSQTOF	G2XSQTOF	NNP	O
mass	mass	NN	O
spectrometer	spectrometer	NN	O
Waters	Waters	NNP	O
,	,	,	O
Manchester	Manchester	NNP	O
,	,	,	O
NH	NH	NNP	O
.	.	.	O

Data	datum	NNS	O
were	be	VBD	O
acquired	acquire	VBN	O
using	use	VBG	O
MassLynx	MassLynx	NNP	O
software	software	NN	O
.	.	.	O

For	for	IN	O
liquid	liquid	JJ	O
chromatography	chromatography	NN	O
,	,	,	O
an	an	DT	O
Acquity	Acquity	NNP	O
UPLC	uplc	NN	O
BEH	BEH	NNP	O
C18	C18	NNP	O
2.1âÃâ50âmm	2.1âãâ50âmm	CD	O
1.7âÂµm	1.7ââµm	CD	O
,	,	,	O
Waters	Waters	NNP	O
column	column	NN	O
was	be	VBD	O
used	use	VBN	O
.	.	.	O

Water	water	NN	O
was	be	VBD	O
used	use	VBN	O
as	as	IN	O
mobile	mobile	JJ	O
phase	phase	NN	O
A	a	NN	O
,	,	,	O
while	while	IN	O
acetonitrile	acetonitrile	NNP	O
was	be	VBD	O
used	use	VBN	O
as	as	IN	O
mobile	mobile	JJ	O
phase	phase	NN	O
B	b	NN	O
in	in	IN	O
a	a	DT	O
gradient	gradient	JJ	O
elution	elution	NN	O
mode	mode	NN	O
.	.	.	O

The	the	DT	O
flow	flow	NN	O
rate	rate	NN	O
was	be	VBD	O
0.4âml	0.4âml	NNP	O
/	/	SYM	O
min	min	NN	O
at	at	IN	O
45âÂ	45ââ	CD	O
°	°	,	O
C	C	NNP	O
and	and	CC	O
the	the	DT	O
gradient	gradient	JJ	O
composition	composition	NN	O
was	be	VBD	O
5	5	CD	O
%	%	NN	O
of	of	IN	O
B	b	NN	O
initial	initial	JJ	O
,	,	,	O
95	95	CD	O
%	%	NN	O
B	b	NN	O
8.0âmin	8.0âmin	NNP	O
,	,	,	O
95	95	CD	O
%	%	NN	O
B	b	NN	O
8.5âmin	8.5âmin	NNP	O
,	,	,	O
5	5	CD	O
%	%	NN	O
B	b	NN	O
8.60âmin	8.60âmin	CD	O
,	,	,	O
with	with	IN	O
1.4âmin	1.4âmin	NNS	O
left	leave	VBN	O
for	for	IN	O
column	column	NN	O
re	re	NN	O
-	-	NN	O
equilibration	equilibration	NN	O
,	,	,	O
resulting	result	VBG	O
in	in	IN	O
a	a	DT	O
10âmin	10âmin	CD	O
analysis	analysis	NN	O
overall	overall	RB	O
;	;	:	O
the	the	DT	O
injection	injection	NN	O
volume	volume	NN	O
was	be	VBD	O
0.1âÂµL.	0.1âÂµL.	NNP	O
For	for	IN	O
mass	mass	NN	O
spectrometry	spectrometry	NN	O
,	,	,	O
data	datum	NNS	O
were	be	VBD	O
acquired	acquire	VBN	O
in	in	IN	O
positive	positive	JJ	O
and	and	CC	O
negative	negative	JJ	O
modes	mode	NNS	O
.	.	.	O

For	for	IN	O
positive	positive	JJ	O
mode	mode	NN	O
,	,	,	O
electrospray	electrospray	IN	O
ionisation	ionisation	NN	O
source	source	NN	O
parameters	parameter	NNS	O
were	be	VBD	O
set	set	VBN	O
as	as	IN	O
follows	follow	VBZ	O
:	:	:	O
capillary	capillary	JJ	O
voltage	voltage	NN	O
of	of	IN	O
3000âV	3000âV	NNP	O
,	,	,	O
sampling	sample	VBG	O
cone	cone	NN	O
of	of	IN	O
40âV	40âV	NNP	O
,	,	,	O
source	source	NN	O
temperature	temperature	NN	O
of	of	IN	O
150âÂ	150ââ	CD	O
°	°	,	O
C	C	NNP	O
,	,	,	O
desolvatation	desolvatation	NN	O
temperature	temperature	NN	O
of	of	IN	O
450âÂ	450ââ	CD	O
°	°	,	O
C	C	NNP	O
,	,	,	O
cone	cone	NN	O
gas	gas	NN	O
flow	flow	NN	O
of	of	IN	O
50âL	50âl	NN	O
/	/	SYM	O
h	h	NN	O
,	,	,	O
and	and	CC	O
desolvatation	desolvatation	NN	O
gas	gas	NN	O
flow	flow	NN	O
of	of	IN	O
900âL	900âl	CD	O
/	/	SYM	O
h	h	NN	O
.	.	.	O

For	for	IN	O
negative	negative	JJ	O
mode	mode	NN	O
:	:	:	O
capillary	capillary	JJ	O
voltage	voltage	NN	O
of	of	IN	O
2500âV	2500âV	NNP	O
,	,	,	O
sampling	sample	VBG	O
cone	cone	NN	O
of	of	IN	O
40âV	40âV	NNP	O
,	,	,	O
source	source	NN	O
temperature	temperature	NN	O
of	of	IN	O
150âÂ	150ââ	CD	O
°	°	,	O
C	C	NNP	O
,	,	,	O
desolvation	desolvation	NN	O
temperature	temperature	NN	O
of	of	IN	O
450âÂ	450ââ	CD	O
°	°	,	O
C	C	NNP	O
,	,	,	O
cone	cone	NN	O
gas	gas	NN	O
flow	flow	NN	O
of	of	IN	O
50âL	50âl	NN	O
/	/	SYM	O
h	h	NN	O
,	,	,	O
and	and	CC	O
desolvation	desolvation	NN	O
gas	gas	NN	O
flow	flow	NN	O
of	of	IN	O
900âL	900âl	CD	O
/	/	SYM	O
h	h	NN	O
.	.	.	O

The	the	DT	O
acquisition	acquisition	NN	O
scan	scan	JJ	O
range	range	NN	O
was	be	VBD	O
from	from	IN	O
100	100	CD	O
to	to	IN	O
1000âDa	1000âda	CD	O
,	,	,	O
and	and	CC	O
the	the	DT	O
data	datum	NNS	O
were	be	VBD	O
acquired	acquire	VBN	O
using	use	VBG	O
the	the	DT	O
MSE	MSE	NNP	O
approach	approach	NN	O
.	.	.	O

Leucine	Leucine	NNP	O
encephalin	encephalin	NNP	O
molecular	molecular	NNP	O
mass	mass	NN	O
of	of	IN	O
555.62	555.62	CD	O
;	;	:	O
200âpg	200âpg	CD	O
/	/	SYM	O
ÂµL	âµl	NN	O
in	in	IN	O
1:1	1:1	NNP	O
ACN	ACN	NNP	O
:	:	:	O
H2O	h2o	NN	O
was	be	VBD	O
used	use	VBN	O
as	as	IN	O
a	a	DT	O
lock	lock	JJ	O
mass	mass	NN	O
for	for	IN	O
accurate	accurate	JJ	O
mass	mass	NN	O
measurements	measurement	NNS	O
and	and	CC	O
a	a	DT	O
0.5âmmol	0.5âmmol	NNP	O
/	/	SYM	O
L	l	NN	O
sodium	sodium	NN	O
formate	formate	NN	O
solution	solution	NN	O
was	be	VBD	O
used	use	VBN	O
for	for	IN	O
instrument	instrument	NN	O
calibration	calibration	NN	O
.	.	.	O

Progenesis	progenesis	NN	O
QI	QI	NNP	O
Waters	Waters	NNP	O
was	be	VBD	O
used	use	VBN	O
for	for	IN	O
peak	peak	NN	O
detection	detection	NN	O
,	,	,	O
alignment	alignment	NN	O
,	,	,	O
deconvolution	deconvolution	NN	O
,	,	,	O
data	datum	NNS	O
filtering	filtering	NN	O
,	,	,	O
ion	ion	NN	O
annotation	annotation	NN	O
and	and	CC	O
MSE	MSE	NNP	O
-	-	HYPH	O
based	base	VBN	O
putative	putative	JJ	O
identification	identification	NN	O
results	result	NNS	O
of	of	IN	O
LCâMS	lcâms	JJ	O
raw	raw	JJ	O
data	datum	NNS	O
prior	prior	RB	O
to	to	IN	O
statistical	statistical	JJ	O
analysis	analysis	NN	O
.	.	.	O

PolyPhenols_PubChemID_v2013.24.11.01	PolyPhenols_PubChemID_v2013.24.11.01	NNS	O

database	database	NN	O
was	be	VBD	O
used	use	VBN	O
for	for	IN	O
identification	identification	NN	O
with	with	IN	O
the	the	DT	O
following	follow	VBG	O
search	search	NN	O
parameters	parameter	NNS	O
:	:	:	O
precursor	precursor	NN	O
mass	mass	NN	O
error	error	NN	O
â¤5âppm	â¤5âppm	NNP	O
,	,	,	O
fragment	fragment	NN	O
tolerance	tolerance	NN	O
â¤10âppm	â¤10âppm	NNP	O
.	.	.	O

Fragmentation	fragmentation	NN	O
score	score	NN	O
,	,	,	O
mass	mass	NN	O
accuracy	accuracy	NN	O
,	,	,	O
and	and	CC	O
isotope	isotope	NN	O
similarity	similarity	NN	O
were	be	VBD	O
considered	consider	VBN	O
for	for	IN	O
the	the	DT	O
identification	identification	NN	O
of	of	IN	O
the	the	DT	O
molecules	molecule	NNS	O
.	.	.	O

To	to	TO	O
find	find	VB	O
any	any	DT	O
significant	significant	JJ	O
differences	difference	NNS	O
between	between	IN	O
the	the	DT	O
infusion	infusion	NN	O
before	before	IN	O
and	and	CC	O
after	after	IN	O
the	the	DT	O
enzymatic	enzymatic	JJ	O
modification	modification	NN	O
had	have	VBD	O
been	be	VBN	O
performed	perform	VBN	O
,	,	,	O
univariate	univariate	JJ	O
statistical	statistical	JJ	O
analyses	analysis	NNS	O
were	be	VBD	O
applied	apply	VBN	O
using	use	VBG	O
the	the	DT	O
MetaboAnalyst	MetaboAnalyst	NNP	O
4.0	4.0	CD	O
web	web	NN	O
platform	platform	NN	O
http://www.metaboanalyst.ca	http://www.metaboanalyst.ca	NFP	O
.	.	.	O

Data	datum	NNS	O
were	be	VBD	O
normalised	normalise	VBN	O
by	by	IN	O
sum	sum	NN	O
and	and	CC	O
pareto	pareto	NN	O
scaled	scale	VBN	O
before	before	IN	O
performing	perform	VBG	O
statistics	statistic	NNS	O
.	.	.	O

Fold	fold	VB	O
change	change	NN	O
FC	fc	NN	O
,	,	,	O
T	t	NN	O
-	-	HYPH	O
test	test	NN	O
,	,	,	O
and	and	CC	O
Volcano	Volcano	NNP	O
plot	plot	NN	O
methods	method	NNS	O
were	be	VBD	O
applied	apply	VBN	O
.	.	.	O

Only	only	RB	O
features	feature	VBZ	O
that	that	WDT	O
fulfilled	fulfil	VBD	O
log2(FC	log2(FC	.	O
>	>	NNP	O
2	2	CD	O
,	,	,	O
p	p	NN	O
values	value	NNS	O
<	<	XX	O
.05	.05	NFP	O

and	and	CC	O
FDR	FDR	NNP	O
<	<	XX	O
0.05	0.05	CD	O
were	be	VBD	O
considered	consider	VBN	O
significant	significant	JJ	O
.	.	.	O

Solutions	solution	NNS	O
were	be	VBD	O
analysed	analyse	VBN	O
in	in	IN	O
quadruplicate	quadruplicate	NN	O
.	.	.	O

The	the	DT	O
antioxidant	antioxidant	JJ	O
activity	activity	NN	O
of	of	IN	O
samples	sample	NNS	O
was	be	VBD	O
assessed	assess	VBN	O
on	on	IN	O
the	the	DT	O
basis	basis	NN	O
of	of	IN	O
the	the	DT	O
scavenging	scavenging	JJ	O
activity	activity	NN	O
of	of	IN	O
the	the	DT	O
stable	stable	JJ	O
2	2	CD	O
,	,	,	O
2-diphenylpicrylhydrazyl	2-diphenylpicrylhydrazyl	CD	O
free	free	JJ	O
radical	radical	NN	O
DPPHâ¢	DPPHâ¢	NNP	O
.	.	.	O

Approximately	approximately	RB	O
,	,	,	O
250âÂµL	250ââµl	CD	O
of	of	IN	O
a	a	DT	O
methanolic	methanolic	JJ	O
solution	solution	NN	O
of	of	IN	O
DPPHâ¢	DPPHâ¢	NNP	O
0.02âmg	0.02âmg	NNP	O
/	/	SYM	O
L	L	NNP	O
was	be	VBD	O
added	add	VBN	O
to	to	IN	O
40âÂµL	40ââµl	CD	O
of	of	IN	O
aqueous	aqueous	JJ	O
infusion	infusion	NN	O
in	in	IN	O
acetate	acetate	NNP	O
buffer	buffer	NNP	O
0.3âM	0.3âM	NNP	O
,	,	,	O
pH	pH	NNP	O
3.8	3.8	CD	O
or	or	CC	O
methanol	methanol	NN	O
,	,	,	O
in	in	IN	O
the	the	DT	O
case	case	NN	O
of	of	IN	O
control	control	NN	O
.	.	.	O

Flasks	flask	NNS	O
were	be	VBD	O
incubated	incubate	VBN	O
at	at	IN	O
25âÂ	25ââ	CD	O
°	°	,	O
C	C	NNP	O
for	for	IN	O
25âmin	25âmin	CD	O
and	and	CC	O
absorbance	absorbance	NN	O
was	be	VBD	O
determined	determine	VBN	O
at	at	IN	O
517ânm	517ânm	CD	O
.	.	.	O

All	all	DT	O
assays	assays	RB	O
were	be	VBD	O
performed	perform	VBN	O
in	in	IN	O
triplicate	triplicate	NN	O
.	.	.	O

The	the	DT	O
scavenging	scavenging	JJ	O
capacity	capacity	NN	O
of	of	IN	O
the	the	DT	O
DPPH	DPPH	NNP	O
radical	radical	NN	O
was	be	VBD	O
calculated	calculate	VBN	O
using	use	VBG	O
the	the	DT	O
following	follow	VBG	O
equation	equation	NN	O
:	:	:	O
DPPHâ¢Â	DPPHâ¢Â	NNP	O
scavengingÂ	scavengingÂ	NNP	O
effectÂ	effectâ	UH	O
%	%	NN	O
Â	Â	NNP	O
=	=	NN	O
Â	Â	NNP	O
AcÂ	AcÂ	NNP	O
âÂ	âÂ	NNP	O
As	as	IN	O
/	/	,	O
Ac)Â	Ac)Â	NNP	O
ÃÂ	ãâ	NN	O
100	100	CD	O
,	,	,	O
where	where	WRB	O
Ac	Ac	NNP	O
and	and	CC	O
As	as	IN	O
are	be	VBP	O
absorbance	absorbance	NN	O
values	value	NNS	O
of	of	IN	O
control	control	NN	O
reaction	reaction	NN	O
and	and	CC	O
test	test	NN	O
samples	sample	NNS	O
,	,	,	O
respectively	respectively	RB	O
.	.	.	O

The	the	DT	O
inhibitory	inhibitory	JJ	O
effect	effect	NN	O
of	of	IN	O
chamomile	chamomile	NN	O
toward	toward	IN	O
digestive	digestive	JJ	O
enzymes	enzyme	NNS	O
was	be	VBD	O
evaluated	evaluate	VBN	O
using	use	VBG	O
both	both	DT	O
native	native	JJ	O
infusion	infusion	NN	O
and	and	CC	O
the	the	DT	O
enzymatically	enzymatically	RB	O
modified	modify	VBN	O
infusion	infusion	NN	O
.	.	.	O

The	the	DT	O
Î±-amylase	Î±-amylase	NNP	O
activity	activity	NN	O
was	be	VBD	O
determined	determine	VBN	O
using	use	VBG	O
starch	starch	NN	O
as	as	IN	O
substrate	substrate	NN	O
,	,	,	O
according	accord	VBG	O
to	to	IN	O
the	the	DT	O
methodology	methodology	NN	O
proposed	propose	VBN	O
by	by	IN	O
Kandra	Kandra	NNP	O
etÂ	etÂ	NNP	O
al	al	NNP	O
.	.	.	B
.	.	.	O

50âÂµL	50ââµl	CD	O
of	of	IN	O
the	the	DT	O
chamomile	chamomile	NN	O
infusions	infusion	NNS	O
and	and	CC	O
50âÂµL	50ââµl	CD	O
of	of	IN	O
Î±-amylase	Î±-amylase	NNP	O
50	50	CD	O

units	unit	NNS	O
/	/	SYM	O
mg	mg	NNP	O
were	be	VBD	O
pre	pre	VBN	O
-	-	VBN	O
incubated	incubate	VBN	O
for	for	IN	O
20âmin	20âmin	CD	O
in	in	IN	O
a	a	DT	O
water	water	NN	O
bath	bath	NN	O
at	at	IN	O
37âÂ	37ââ	CD	O
°	°	,	O
C	C	NNP	O
.	.	.	O

The	the	DT	O
starch	starch	NN	O
1	1	CD	O
%	%	NN	O
,	,	,	O
m	m	NNP	O
/	/	SYM	O
v	v	NNP	O
was	be	VBD	O
prepared	prepare	VBN	O
in	in	IN	O
phosphate	phosphate	JJ	O
buffer	buffer	NN	O
at	at	IN	O
pH	pH	NNP	O
7.0	7.0	CD	O
with	with	IN	O
38âmmol	38âmmol	CD	O
/	/	SYM	O
L	L	NNP	O
NaCl	NaCl	NNP	O
.	.	.	O

After	after	IN	O
the	the	DT	O
addition	addition	NN	O
of	of	IN	O
100âÂµL	100ââµl	CD	O
of	of	IN	O
the	the	DT	O
substrate	substrate	NN	O
,	,	,	O
the	the	DT	O
mixture	mixture	NN	O
was	be	VBD	O
incubated	incubate	VBN	O
for	for	IN	O
2âh	2âh	CD	O
.	.	.	O

The	the	DT	O
product	product	NN	O
glucose	glucose	NN	O
was	be	VBD	O
quantified	quantify	VBN	O
by	by	IN	O
the	the	DT	O
glucose	glucose	NNP	O
oxidase	oxidase	NN	O
-	-	HYPH	O
peroxidase	peroxidase	NN	O
method	method	NN	O
with	with	IN	O
a	a	DT	O
commercial	commercial	JJ	O
kit	kit	NN	O
Labtest	Labtest	NNP	O
and	and	CC	O
measured	measure	VBN	O
at	at	IN	O
520ânm	520ânm	CD	O
.	.	.	O

Phosphate	phosphate	JJ	O
buffer	buffer	NN	O
at	at	IN	O
pH	pH	NNP	O
7.0	7.0	CD	O
was	be	VBD	O
used	use	VBN	O
as	as	IN	O
control	control	NN	O
.	.	.	O

The	the	DT	O
inhibitory	inhibitory	JJ	O
effect	effect	NN	O
on	on	IN	O
Î±-glucosidase	î±-glucosidase	NN	O
was	be	VBD	O
tested	test	VBN	O
according	accord	VBG	O
to	to	IN	O
a	a	DT	O
previously	previously	RB	O
reported	report	VBN	O
protocol	protocol	NN	B
,	,	,	O
using	use	VBG	O
p	p	NN	O
-	-	HYPH	O
nitrophenyl	nitrophenyl	NN	O
Î±-d	Î±-d	NNP	O
-	-	HYPH	O
glucopyranoside	glucopyranoside	NNP	O
as	as	IN	O
a	a	DT	O
substrate	substrate	NN	O
.	.	.	O

Activity	activity	NN	O
was	be	VBD	O
assayed	assay	VBN	O
by	by	IN	O
using	use	VBG	O
50âÂµl	50ââµl	CD	O
of	of	IN	O
the	the	DT	O
chamomile	chamomile	NN	O
infusion	infusion	NN	O
and	and	CC	O
100âÂµl	100ââµl	CD	O
Î±-glucosidase	î±-glucosidase	NN	O
solution	solution	NN	O
1.0âU	1.0âu	CD	O
/	/	SYM	O
ml	ml	NNS	O
in	in	IN	O
0.1âM	0.1âm	CD	O
phosphate	phosphate	NN	O
buffer	buffer	NN	O
pH	pH	NNP	O
7.0	7.0	CD	O
incubated	incubate	VBD	O
in	in	IN	O
a	a	DT	O
water	water	NN	O
bath	bath	NN	O
at	at	IN	O
25âÂ	25ââ	CD	O
°	°	,	O
C	C	NNP	O
for	for	IN	O
10âmin	10âmin	NNP	O
.	.	.	O

After	after	IN	O
preincubation	preincubation	NN	O
,	,	,	O
50âÂµl	50ââµl	CD	O
of	of	IN	O
substrate	substrate	NN	O
5âmM	5âmm	CD	O
p	p	NN	O
-	-	HYPH	O
nitrophenyl	nitrophenyl	NN	O
-	-	HYPH	O
Î±-d	î±-d	NN	O
-	-	HYPH	O
glucopyranoside	glucopyranoside	NN	O
solution	solution	NN	O
in	in	IN	O
0.1âM	0.1âm	CD	O
phosphate	phosphate	NN	O
buffer	buffer	NN	O
pH	pH	NNP	O
7.0	7.0	CD	O
were	be	VBD	O
added	add	VBN	O
to	to	IN	O
each	each	DT	O
tube	tube	NN	O
at	at	IN	O
timed	time	VBN	O
intervals	interval	NNS	O
.	.	.	O

The	the	DT	O
reaction	reaction	NN	O
mixtures	mixture	NNS	O
were	be	VBD	O
incubated	incubate	VBN	O
at	at	IN	O
25âÂ	25ââ	CD	O
°	°	,	O
C	C	NNP	O
for	for	IN	O
5âmin	5âmin	CD	O
.	.	.	O

The	the	DT	O
absorbance	absorbance	NN	O
readings	reading	NNS	O
were	be	VBD	O
recorded	record	VBN	O
at	at	IN	O
405ânm	405ânm	CD	O
and	and	CC	O
phosphate	phosphate	JJ	O
buffer	buffer	NN	O
at	at	IN	O
pH	pH	NNP	O
7.0	7.0	CD	O
was	be	VBD	O
used	use	VBN	O
as	as	IN	O
control	control	NN	O
.	.	.	O

The	the	DT	O
infusion	infusion	NN	O
was	be	VBD	O
analysed	analyse	VBN	O
for	for	IN	O
its	-PRON-	PRP$	O
ability	ability	NN	O
to	to	TO	O
inhibit	inhibit	VB	O
lipase	lipase	NN	O
activity	activity	NN	O
using	use	VBG	O
a	a	DT	O
modified	modify	VBN	O
method	method	NN	O
with	with	IN	O
p	p	NN	O
-	-	HYPH	O
nitrophenyl	nitrophenyl	NN	O
palmitate	palmitate	NN	O
as	as	IN	O
substrate	substrate	NN	O
and	and	CC	O
porcine	porcine	VB	O
pancreatic	pancreatic	JJ	O
lipase	lipase	NN	O
PL	pl	NN	O
)	)	-RRB-	B
.	.	.	O

The	the	DT	O
mixture	mixture	NN	O
of	of	IN	O
100âÂµL	100ââµl	CD	O
of	of	IN	O
pancreatic	pancreatic	JJ	O
lipase	lipase	NN	O
diluted	dilute	VBN	O
in	in	IN	O
50âmM	50âmm	CD	O
TrisâHCl	TrisâHCl	NNP	O
buffer	buffer	NN	O
pH	pH	NNP	O
8.0	8.0	CD	O
,	,	,	O
containing	contain	VBG	O
10âmM	10âmm	CD	O
CaCl2	cacl2	NN	O
and	and	CC	O
25âmM	25âmm	CD	O
NaCl	NaCl	NNP	O
,	,	,	O
50âÂµL	50ââµl	CD	O
of	of	IN	O
the	the	DT	O
infusion	infusion	NN	O
,	,	,	O
and	and	CC	O
50âÂµL	50ââµl	CD	O
of	of	IN	O
4âmmol	4âmmol	CD	O
/	/	SYM	O
L	L	NNP	O
p	p	NN	O
-	-	HYPH	O
nitrophenyl	nitrophenyl	NN	O
palmitate	palmitate	NN	O
0.05âmmol	0.05âmmol	NNP	O
/	/	SYM	O
L	L	NNP	O
TrisâââHCl	TrisâââHCl	NNP	O
buffer	buffer	VBP	O
at	at	IN	O
pH	pH	NNP	O
8.0	8.0	CD	O
was	be	VBD	O
incubated	incubate	VBN	O
for	for	IN	O
30âmin	30âmin	NNP	O
.	.	.	O

The	the	DT	O
reaction	reaction	NN	O
was	be	VBD	O
stopped	stop	VBN	O
,	,	,	O
transferring	transfer	VBG	O
the	the	DT	O
tubes	tube	NNS	O
to	to	IN	O
an	an	DT	O
ice	ice	NN	O
bath	bath	NN	O
and	and	CC	O
adding	add	VBG	O
500âÂµL	500ââµl	CD	O
of	of	IN	O
0.05âmmol	0.05âmmol	NNP	O
/	/	SYM	O
L	L	NNP	O
TrisâââHCl	TrisâââHCl	NNP	O
buffer	buffer	VBP	O
at	at	IN	O
pH	pH	NNP	O
8.0	8.0	CD	O
.	.	.	O

The	the	DT	O
absorbance	absorbance	NN	O
readings	reading	NNS	O
were	be	VBD	O
recorded	record	VBN	O
at	at	IN	O
405ânm	405ânm	CD	O
and	and	CC	O
TrisâHCl	TrisâHCl	NNP	O
buffer	buffer	NN	O
pH	pH	NNP	O
8.0	8.0	CD	O
was	be	VBD	O
used	use	VBN	O
as	as	IN	O
control	control	NN	O
.	.	.	O

The	the	DT	O
concentration	concentration	NN	O
of	of	IN	O
inhibitors	inhibitor	NNS	O
required	require	VBN	O
for	for	IN	O
inhibiting	inhibit	VBG	O
50	50	CD	O
%	%	NN	O
of	of	IN	O
the	the	DT	O
lipase	lipase	NN	O
activity	activity	NN	O
under	under	IN	O
the	the	DT	O
assay	assay	NNP	O
conditions	condition	NNS	O
was	be	VBD	O
defined	define	VBN	O
as	as	IN	O
the	the	DT	O
EC50	EC50	NNP	O

value	value	NN	O
.	.	.	O

All	all	DT	O
analyses	analysis	NNS	O
were	be	VBD	O
performed	perform	VBN	O
in	in	IN	O
triplicate	triplicate	NN	O
and	and	CC	O
results	result	NNS	O
were	be	VBD	O
presented	present	VBN	O
as	as	IN	O
percentage	percentage	NN	O
%	%	NN	O
of	of	IN	O
inhibition	inhibition	NN	O
I	i	NN	O
.	.	.	O

The	the	DT	O
results	result	NNS	O
were	be	VBD	O
calculated	calculate	VBN	O
using	use	VBG	O
the	the	DT	O
following	following	JJ	O
equation	equation	NN	O
:	:	:	O
IÂ	IÂ	NNP	O
%	%	NN	O
Â	Â	NNP	O
=	=	NN	O
Â	â	NN	O
AcontrolâÂ	AcontrolâÂ	NNP	O
Asample)/(Acontrol)]Â	asample)/(acontrol)]â	NN	O
ÃÂ	ãâ	NN	O
100	100	CD	O
,	,	,	O
where	where	WRB	O
Acontrol	Acontrol	NNP	O
is	be	VBZ	O
the	the	DT	O
absorbance	absorbance	NN	O
value	value	NN	O
of	of	IN	O
the	the	DT	O
negative	negative	JJ	O
control	control	NN	O
and	and	CC	O
Asample	Asample	NNP	O
is	be	VBZ	O
the	the	DT	O
absorbance	absorbance	NN	O
value	value	NN	O
of	of	IN	O
the	the	DT	O
chamomile	chamomile	NN	O
sample	sample	NN	O
.	.	.	O

In	in	IN	O
order	order	NN	O
to	to	TO	O
measure	measure	VB	O
the	the	DT	O
MichaelisâMenten	MichaelisâMenten	NNP	O
constant	constant	NN	O
,	,	,	O
Km	Km	NNP	O
,	,	,	O
the	the	DT	O
inhibition	inhibition	NN	O
constant	constant	JJ	O
,	,	,	O
Ki	Ki	NNP	O
,	,	,	O
and	and	CC	O
the	the	DT	O
Vmax	Vmax	NNP	O
maximum	maximum	JJ	O
reaction	reaction	NN	O
rate	rate	NN	O
,	,	,	O
a	a	DT	O
series	series	NN	O
of	of	IN	O
substrate	substrate	JJ	O
concentrations	concentration	NNS	O
200â800âmM	200â800âmm	CD	O
was	be	VBD	O
tested	test	VBN	O
in	in	IN	O
the	the	DT	O
assay	assay	NN	O
system	system	NN	O
.	.	.	O

Each	each	DT	O
analysis	analysis	NN	O
was	be	VBD	O
performed	perform	VBN	O
without	without	IN	O
control	control	NN	O
and	and	CC	O
with	with	IN	O
the	the	DT	O
chamomile	chamomile	NN	O
infusion	infusion	NN	O
as	as	IN	O
inhibitor	inhibitor	NN	O
40	40	CD	O
and	and	CC	O
60âÂµl	60ââµl	CD	O
.	.	.	O

Vmax	Vmax	NNP	O
and	and	CC	O
Km	Km	NNP	O
were	be	VBD	O
calculated	calculate	VBN	O
and	and	CC	O
the	the	DT	O
type	type	NN	O
of	of	IN	O
inhibition	inhibition	NN	O
kinetics	kinetic	NNS	O
was	be	VBD	O
identified	identify	VBN	O
using	use	VBG	O
the	the	DT	O
SigmaPlot	SigmaPlot	NNP	O
software	software	NN	O
Aspire	Aspire	NNP	O
Software	Software	NNP	O
International	International	NNP	O
,	,	,	O
Ashburn	Ashburn	NNP	O
,	,	,	O
VA	VA	NNP	O
.	.	.	O

The	the	DT	O
MichaelisâMenten	MichaelisâMenten	NNP	O
equation	equation	NN	O
linearised	linearise	VBN	O
by	by	IN	O
LineweaverâBurk	LineweaverâBurk	NNP	O
was	be	VBD	O
used	use	VBN	O
to	to	TO	O
determine	determine	VB	O
Vmax	Vmax	NNP	O
and	and	CC	O
Km	Km	NNP	O
by	by	IN	O
plotting	plot	VBG	O
a	a	DT	O
graph	graph	NN	O
,	,	,	O
i.e.	i.e.	FW	O
1	1	CD	O
/	/	SYM	O
V	v	NN	O
against	against	IN	O
1/[substrate	1/[substrate	CD	O
concentration	concentration	NN	O
,	,	,	O
and	and	CC	O
estimated	estimate	VBN	O
by	by	IN	O
the	the	DT	O
intercept	intercept	NN	O
and	and	CC	O
slope	slope	NN	O
,	,	,	O
respectively	respectively	RB	O
.	.	.	O

Statistical	statistical	JJ	O
analyzes	analyze	NNS	O
and	and	CC	O
graphs	graph	NNS	O
were	be	VBD	O
done	do	VBN	O
using	use	VBG	O
GraphPad	GraphPad	NNP	O
Prism	Prism	NNP	O
5.0	5.0	CD	O
software	software	NN	O
.	.	.	O

The	the	DT	O
data	datum	NNS	O
were	be	VBD	O
expressed	express	VBN	O
as	as	IN	O
meanâÂ±âstandard	meanâÂ±âstandard	NNP	O
deviation	deviation	NN	O
SD	SD	NNP	O
and	and	CC	O
the	the	DT	O
significance	significance	NN	O
of	of	IN	O
difference	difference	NN	O
was	be	VBD	O
calculated	calculate	VBN	O
using	use	VBG	O
one	one	CD	O
-	-	HYPH	O
way	way	NN	O
ANOVA	ANOVA	NNP	O
and	and	CC	O
Tukey	Tukey	NNP	O
as	as	IN	O
post	post	JJ	O
-	-	JJ	O
test	test	NN	O
of	of	IN	O
multiple	multiple	JJ	O
comparison	comparison	NN	O
.	.	.	O

Values	value	NNS	O
of	of	IN	O
pâ<â.05	pâ<â.05	NNPS	O
were	be	VBD	O
considered	consider	VBN	O
significant	significant	JJ	O
.	.	.	O

UHPLC	UHPLC	NNP	O
-	-	HYPH	O
Q	Q	NNP	O
-	-	HYPH	O
TOF	TOF	NNP	O
-	-	HYPH	O
MSE	MSE	NNP	O
analysis	analysis	NN	O
of	of	IN	O
the	the	DT	O
chamomile	chamomile	NN	O
infusion	infusion	NN	O
enabled	enable	VBD	O
the	the	DT	O
putative	putative	JJ	O
identification	identification	NN	B
of	of	IN	O
more	more	JJR	O
than	than	IN	O
100	100	CD	O

phenolic	phenolic	JJ	O
compounds	compound	NNS	O
that	that	WDT	O
could	could	MD	O
be	be	VB	O
classified	classify	VBN	O
into	into	IN	O
flavonoid	flavonoid	JJ	O
glycosides	glycoside	NNS	O
and	and	CC	O
derivatives	derivative	NNS	O
of	of	IN	O
hydroxycinnamic	hydroxycinnamic	JJ	O
acid	acid	NN	O
and	and	CC	O
coumarins	coumarin	NNS	O
among	among	IN	O
others	other	NNS	O
.	.	.	O

From	from	IN	O
among	among	IN	O
the	the	DT	O
well	well	RB	O
-	-	HYPH	O
known	know	VBN	O
chamomile	chamomile	NN	O
compounds	compound	NNS	O
described	describe	VBN	O
in	in	IN	O
the	the	DT	O
literature	literature	NN	O
for	for	IN	O
the	the	DT	O
native	native	JJ	O
infusion	infusion	NN	O
,	,	,	O
the	the	DT	O
following	follow	VBG	O
were	be	VBD	O
identified	identify	VBN	O
:	:	:	O
apigenin	apigenin	JJ	O
derivatives	derivative	NNS	O
apigenin-7-apioglucoside	apigenin-7-apioglucoside	IN	O
,	,	,	O
apigenin-7-O	apigenin-7-O	NNS	O
-	-	HYPH	O
glucoside	glucoside	NN	O
and	and	CC	O
apigenin-7-glucuronide	apigenin-7-glucuronide	NNP	O
,	,	,	O
luteoloside	luteoloside	VB	O
,	,	,	O
kaempferol	kaempferol	NNP	O
glycosides	glycoside	NNS	O
,	,	,	O
luteolin	luteolin	NNP	O
,	,	,	O
umbelliferone	umbelliferone	NN	O
,	,	,	O
caffeic	caffeic	NN	O
acid	acid	NN	O
,	,	,	O
rutin	rutin	NNS	O
,	,	,	O
and	and	CC	O
isoquercetin	isoquercetin	NN	O
.	.	.	O

The	the	DT	O
putative	putative	JJ	O
identities	identity	NNS	O
of	of	IN	O
statistically	statistically	RB	O
significant	significant	JJ	O
features	feature	NNS	O
of	of	IN	O
compounds	compound	NNS	O
from	from	IN	O
the	the	DT	O
enzymatic	enzymatic	JJ	O
treatment	treatment	NN	O
of	of	IN	O
the	the	DT	O
infusion	infusion	NN	O
were	be	VBD	O
investigated	investigate	VBN	O
by	by	IN	O
comparing	compare	VBG	O
fragmentation	fragmentation	NN	O
pattern	pattern	NN	O
data	datum	NNS	O
acquired	acquire	VBN	O
using	use	VBG	O
an	an	DT	O
MSE	MSE	NNP	O
approach	approach	NN	O
with	with	IN	O
the	the	DT	O
available	available	JJ	O
metabolite	metabolite	JJ	O
database	database	NN	O
.	.	.	O

A	a	DT	O
wide	wide	JJ	O
variety	variety	NN	O
of	of	IN	O
secondary	secondary	JJ	O
metabolites	metabolite	NNS	O
were	be	VBD	O
altered	alter	VBN	O
with	with	IN	O
the	the	DT	O
enzymatic	enzymatic	JJ	O
treatment	treatment	NN	O
and	and	CC	O
the	the	DT	O
main	main	JJ	O
ones	one	NNS	O
are	be	VBP	O
shown	show	VBN	O
in	in	IN	O
the	the	DT	O
Table	table	NN	O
1	1	CD	O
and	and	CC	O
Figure	figure	NN	O
1	1	CD	O
.	.	.	O

Putative	putative	JJ	O
identification	identification	NN	O
of	of	IN	O
statistically	statistically	RB	O
significant	significant	JJ	O
secondary	secondary	JJ	O
metabolites	metabolite	NNS	O
from	from	IN	O
chamomile	chamomile	NN	O
infusion	infusion	NN	O
and	and	CC	O
the	the	DT	O
relative	relative	JJ	O
tendency	tendency	NN	O
after	after	IN	O
the	the	DT	O
enzymatic	enzymatic	JJ	O
treatment.aFeature	treatment.afeature	NN	O
:	:	:	O
mass	mass	NN	O
-	-	HYPH	O
to	to	TO	O
charge	charge	VB	O
ratio	ratio	NN	O
and	and	CC	O
retention	retention	NN	O
time	time	NN	O
pairs	pair	NNS	O
,	,	,	O
bFalse	bFalse	NNP	O
Discovered	Discovered	NNP	O
Ratio	Ratio	NNP	O
FDR	FDR	NNP	O
adjusted	adjust	VBD	O
,	,	,	O
cCalculated	cCalculated	NNP	O
in	in	IN	O
comparison	comparison	NN	O
with	with	IN	O
theoretical	theoretical	JJ	O
value	value	NN	O
,	,	,	O
dPutative	dPutative	NNP	O
Identity	Identity	NNP	O
ID	ID	NNP	O
All	all	DT	O
listed	list	VBN	O
compounds	compound	NNS	O
reached	reach	VBD	O
level	level	NN	O
2	2	CD	O
identification	identification	NN	O
,	,	,	O
except	except	IN	O
for	for	IN	O
feature	feature	NN	O
numbers	number	NNS	O
4	4	CD	O
,	,	,	O
16	16	CD	O
,	,	,	O
17	17	CD	O
and	and	CC	O
22	22	CD	O
that	that	WDT	O
reached	reach	VBD	O
level	level	NN	O
3	3	CD	O
.	.	.	O

eIn	eIn	NNS	O
product	product	NN	O
of	of	IN	O
hydrolysis	hydrolysis	NN	O
when	when	WRB	O
compared	compare	VBN	O
to	to	IN	O
native	native	JJ	O
chamomilla	chamomilla	NN	O
infusion	infusion	NN	O
.	.	.	O

Table	table	NN	O
1	1	CD	O
shows	show	VBZ	O
30	30	CD	O
compounds	compound	NNS	O
putatively	putatively	RB	O
identified	identify	VBN	O
by	by	IN	O
UHPLC	UHPLC	NNP	O
-	-	HYPH	O
Q	Q	NNP	O
-	-	HYPH	O
TOF	TOF	NNP	O
-	-	HYPH	O
MSE	MSE	NNP	O
that	that	WDT	O
were	be	VBD	O
altered	alter	VBN	O
with	with	IN	O
the	the	DT	O
enzymatic	enzymatic	JJ	O
treatment	treatment	NN	O
and	and	CC	O
possibly	possibly	RB	O
involved	involve	VBN	O
in	in	IN	O
the	the	DT	O
antioxidant	antioxidant	JJ	O
activity	activity	NN	O
of	of	IN	O
chamomile	chamomile	NN	O
infusion	infusion	NN	O
.	.	.	O

Hydroxylated	hydroxylate	VBN	O
phenolic	phenolic	JJ	O
acids	acid	NNS	O
such	such	JJ	O
as	as	IN	O
2-hydroxy	2-hydroxy	CD	O
cinnamic	cinnamic	NN	O
acid	acid	NN	O
,	,	,	O
4-hydroxy-3,5-dimethoxycinnamic	4-hydroxy-3,5-dimethoxycinnamic	CD	O
acid	acid	NN	O
,	,	,	O
hydroxybenzoic	hydroxybenzoic	NNP	O
acid	acid	NNP	O
,	,	,	O
hydroxyferulic	hydroxyferulic	JJ	O
acid	acid	NN	O
,	,	,	O
and	and	CC	O
caffeic	caffeic	NN	O
acid	acid	NN	O
and	and	CC	O
aglycones	aglycones	NNP	O
hispidulin	hispidulin	NNP	O
and	and	CC	O
hespertin	hespertin	NNP	O
were	be	VBD	O
increased	increase	VBN	O
;	;	:	O
while	while	IN	O
glycosyl	glycosyl	NN	O
isoflavone	isoflavone	NN	O
forms	form	NNS	O
malonylglycitin	malonylglycitin	NNP	O
and	and	CC	O
6â³-O	6â³-o	JJ	O
-	-	HYPH	O
acetylgenistin	acetylgenistin	NNP	O
and	and	CC	O
other	other	JJ	O
free	free	JJ	O
phenolic	phenolic	NN	O
acids	acid	NNS	O
cinnamic	cinnamic	VB	O
and	and	CC	O
trans	trans	JJ	O
-	-	JJ	O
cinnamic	cinnamic	JJ	O
acids	acid	NNS	O
were	be	VBD	O
significantly	significantly	RB	O
reduced	reduce	VBN	O
after	after	IN	O
enzymatic	enzymatic	JJ	O
treatment	treatment	NN	O
.	.	.	O

In	in	IN	O
addition	addition	NN	O
,	,	,	O
LCâMSE	lcâmse	CD	O
putatively	putatively	RB	O
identified	identify	VBN	O
rutinoside	rutinoside	NN	O
,	,	,	O
galactoside	galactoside	NNP	O
,	,	,	O
and	and	CC	O
neohesperidoside	neohesperidoside	NN	O
of	of	IN	O
quercetin	quercetin	NNP	O
and	and	CC	O
kampferol	kampferol	NNP	O
,	,	,	O
which	which	WDT	O
had	have	VBD	O
a	a	DT	O
tendency	tendency	NN	O
to	to	TO	O
reduce	reduce	VB	O
due	due	IN	O
to	to	IN	O
enzymatic	enzymatic	JJ	O
hydrolysis	hydrolysis	NN	O
.	.	.	O

Figure	figure	NN	O
1	1	CD	O
shows	show	VBZ	O
the	the	DT	O
boxplot	boxplot	NN	O
obtained	obtain	VBN	O
with	with	IN	O
normalised	normalised	JJ	O
intensities	intensity	NNS	O
of	of	IN	O
altered	alter	VBN	O
flavonoids	flavonoid	NNS	O
.	.	.	O

The	the	DT	O
glycosylated	glycosylated	JJ	O
flavonoids	flavonoid	NNS	O
,	,	,	O
esculin	esculin	NNP	O
esculetin	esculetin	NNP	O
6-Î²-d	6-î²-d	CD	O
-	-	HYPH	O
glucoside	glucoside	NN	O
,	,	,	O
luteoloside	luteoloside	VB	O
luteolin	luteolin	NNP	O
7-O	7-o	CD	O
-	-	HYPH	O
glucoside	glucoside	NN	O
and	and	CC	O
rutin	rutin	NN	O
quercetin	quercetin	UH	O
,	,	,	O
3-rhamnosyl	3-rhamnosyl	CD	O
-	-	HYPH	O
glucoside	glucoside	NN	O
,	,	,	O
were	be	VBD	O
reduced	reduce	VBN	O
,	,	,	O
while	while	IN	O
their	-PRON-	PRP$	O
aglycones	aglycones	NNP	O
esculetin	esculetin	NN	O
and	and	CC	O
luteolin	luteolin	NNP	O
were	be	VBD	O
increased	increase	VBN	O
.	.	.	O

The	the	DT	O
aglycone	aglycone	NN	O
form	form	NN	O
of	of	IN	O
rutin	rutin	NN	O
quercetin	quercetin	UH	O
has	have	VBZ	O
not	not	RB	O
been	be	VBN	O
identified	identify	VBN	O
as	as	IN	O
a	a	DT	O
differential	differential	JJ	O
metabolite	metabolite	NN	O
.	.	.	O

In	in	IN	O
addition	addition	NN	O
,	,	,	O
umbelliferone	umbelliferone	NN	O
,	,	,	O
a	a	DT	O
natural	natural	JJ	O
product	product	NN	O
of	of	IN	O
the	the	DT	O
coumarin	coumarin	NNP	O
family	family	NN	O
was	be	VBD	O
significantly	significantly	RB	O
increased	increase	VBN	O
after	after	IN	O
enzymatic	enzymatic	JJ	O
treatment	treatment	NN	O
.	.	.	O

Table	table	NN	O
2	2	CD	O
shows	show	VBZ	O
antioxidant	antioxidant	JJ	O
activity	activity	NN	O
and	and	CC	O
the	the	DT	O
effect	effect	NN	O
of	of	IN	O
chamomile	chamomile	NN	O
infusion	infusion	NN	O
on	on	IN	O
digestive	digestive	JJ	O
enzyme	enzyme	NNS	O
activities	activity	NNS	O
in	in	IN	O
the	the	DT	O
absence	absence	NN	O
control	control	NN	O
and	and	CC	O
presence	presence	NN	O
of	of	IN	O
the	the	DT	O
inhibitors	inhibitor	NNS	O
infusion	infusion	NN	O
before	before	IN	O
and	and	CC	O
after	after	IN	O
enzymatic	enzymatic	JJ	O
treatment	treatment	NN	O
.	.	.	O

DPPHâ¢	DPPHâ¢	NNP	O
scavenging	scavenge	VBG	O
activity	activity	NN	O
%	%	NN	O
and	and	CC	O
kinetic	kinetic	JJ	O
parameters	parameter	NNS	O
of	of	IN	O
inhibitory	inhibitory	JJ	O
effect	effect	NN	O
of	of	IN	O
chamomile	chamomile	NN	O
infusion	infusion	NN	O
toward	toward	IN	O
digestive	digestive	JJ	O
enzymes	enzyme	NNS	O
activities	activity	NNS	O
in	in	IN	O
the	the	DT	O
absence	absence	NN	O
control	control	NN	O
and	and	CC	O
presence	presence	NN	O
of	of	IN	O
the	the	DT	O
inhibitors	inhibitor	NNS	O
40	40	CD	O
and	and	CC	O
60âÂµM	60ââµm	CD	O
.	.	.	O

Results	result	NNS	O
are	be	VBP	O
expressed	express	VBN	O
as	as	IN	O
the	the	DT	O
meanâÂ±âstandard	meanâÂ±âstandard	NNP	O
deviation	deviation	NN	O
SD	SD	NNP	O
of	of	IN	O
three	three	CD	O
determinations	determination	NNS	O
.	.	.	O

Means	mean	NNS	O
within	within	IN	O
a	a	DT	O
line	line	NN	O
with	with	IN	O
different	different	JJ	O
superscript	superscript	NN	O
letters	letter	NNS	O
are	be	VBP	O
significantly	significantly	RB	O
different	different	JJ	O
pâ<â.05	pâ<â.05	NNPS	O
.	.	.	O

The	the	DT	O
DPPHâ	dpphâ	NN	O
method	method	NN	O
was	be	VBD	O
used	use	VBN	O
to	to	TO	O
evaluate	evaluate	VB	O
the	the	DT	O
hydrogen	hydrogen	NN	O
donating	donate	VBG	O
ability	ability	NN	O
,	,	,	O
and	and	CC	O
the	the	DT	O
antioxidant	antioxidant	JJ	O
activity	activity	NN	O
of	of	IN	O
the	the	DT	O
samples	sample	NNS	O
was	be	VBD	O
expressed	express	VBN	O
as	as	IN	O
the	the	DT	O
percentage	percentage	NN	O
of	of	IN	O
DPPH	DPPH	NNP	O
radical	radical	JJ	O
-	-	HYPH	O
scavenging	scavenge	VBG	O
activity	activity	NN	O
%	%	NN	O
.	.	.	O

The	the	DT	O
enzymatic	enzymatic	JJ	O
treatment	treatment	NN	O
led	lead	VBD	O
to	to	IN	O
an	an	DT	O
increase	increase	NN	O
of	of	IN	O
approximately	approximately	RB	O
12	12	CD	O
%	%	NN	O
in	in	IN	O
the	the	DT	O
antioxidant	antioxidant	JJ	O
activity	activity	NN	O
of	of	IN	O
enzymatically	enzymatically	RB	O
modified	modify	VBN	O
infusion	infusion	NN	O
in	in	IN	O
relation	relation	NN	O
to	to	IN	O
the	the	DT	O
values	value	NNS	O
observed	observe	VBN	O
for	for	IN	O
native	native	JJ	O
chamomile	chamomile	NN	O
infusion	infusion	NN	O
.	.	.	O

A	a	DT	O
period	period	NN	O
longer	long	JJR	O
than	than	IN	O
8âh	8âh	CD	O
of	of	IN	O
enzymatic	enzymatic	JJ	O
treatment	treatment	NN	O
showed	show	VBD	O
no	no	DT	O
apparent	apparent	JJ	O
change	change	NN	O
of	of	IN	O
antioxidant	antioxidant	JJ	O
activity	activity	NN	O
date	date	NN	O
not	not	RB	O
shown	show	VBN	O
.	.	.	O

In	in	IN	O
the	the	DT	O
Î±-glucosidase	î±-glucosidase	NN	O
inhibition	inhibition	NN	O
assay	assay	NNP	O
,	,	,	O
the	the	DT	O
modified	modify	VBN	O
infusion	infusion	NN	O
at	at	IN	O
60âÂµM	60ââµm	CD	O
showed	show	VBD	O
higher	high	JJR	O
inhibitory	inhibitory	JJ	O
activity	activity	NN	O
than	than	IN	O
the	the	DT	O
native	native	JJ	O
one	one	CD	O
56.9âÂ±â3.7	56.9ââ±â3.7	CD	O
%	%	NN	O
and	and	CC	O
37.4âÂ±â5.6	37.4ââ±â5.6	CD	O
%	%	NN	O
,	,	,	O
respectively	respectively	RB	O
.	.	.	O

At	at	IN	O
the	the	DT	O
same	same	JJ	O
concentration	concentration	NN	O
,	,	,	O
lipase	lipase	NN	O
inhibition	inhibition	NN	O
reached	reach	VBD	O
73.6âÂ±â3.2	73.6ââ±â3.2	CD	O
%	%	NN	O
,	,	,	O
while	while	IN	O
native	native	JJ	O
infusion	infusion	NN	O
only	only	RB	O
showed	show	VBD	O
39.2âÂ±â5.7	39.2ââ±â5.7	CD	O
%	%	NN	O
of	of	IN	O
inhibition	inhibition	NN	O
pâ=â.0008	pâ=â.0008	NNP	O
.	.	.	O

The	the	DT	O
response	response	NN	O
of	of	IN	O
the	the	DT	O
modified	modify	VBN	O
flavonoids	flavonoid	NNS	O
in	in	IN	O
inhibiting	inhibit	VBG	O
lipase	lipase	NN	O
activity	activity	NN	O
is	be	VBZ	O
directly	directly	RB	O
proportional	proportional	JJ	O
to	to	IN	O
their	-PRON-	PRP$	O
concentrations	concentration	NNS	O
and	and	CC	O
the	the	DT	O
EC50	EC50	NNP	O
value	value	NN	O
was	be	VBD	O
35.6âÂµM.	35.6âÂµM.	NNP	O
With	with	IN	O
regard	regard	NN	O
to	to	IN	O
the	the	DT	O
Î±-amylase	Î±-amylase	NNP	O
assay	assay	NNP	O
,	,	,	O
all	all	DT	O
infusions	infusion	NNS	O
presented	present	VBD	O
low	low	JJ	O
inhibitory	inhibitory	JJ	O
effect	effect	NN	O
both	both	CC	O
before	before	IN	O
and	and	CC	O
after	after	IN	O
the	the	DT	O
enzymatic	enzymatic	JJ	O
treatment	treatment	NN	O
.	.	.	O

At	at	IN	O
the	the	DT	O
maximum	maximum	JJ	O
concentration	concentration	NN	O
assessed	assess	VBD	O
,	,	,	O
the	the	DT	O
enzymatically	enzymatically	RB	O
modified	modify	VBN	O
chamomile	chamomile	NN	O
infusion	infusion	NN	O
exerted	exert	VBD	O
a	a	DT	O
non	non	JJ	O
-	-	JJ	O
significant	significant	JJ	O
effect	effect	NN	O
on	on	IN	O
the	the	DT	O
kinetics	kinetic	NNS	O
of	of	IN	O
the	the	DT	O
reaction	reaction	NN	O
catalysed	catalyse	VBN	O
by	by	IN	O
Î±-amylase	Î±-amylase	NNP	O
and	and	CC	O
a	a	DT	O
small	small	JJ	O
effect	effect	NN	O
on	on	IN	O
Î±-glucosidase	î±-glucosidase	NN	O
activity	activity	NN	O
.	.	.	O

There	there	EX	O
was	be	VBD	O
an	an	DT	O
observable	observable	JJ	O
decrease	decrease	NN	O
in	in	IN	O
the	the	DT	O
Vmax	Vmax	NNP	O
values	value	NNS	O
of	of	IN	O
0.79âÂ±â0.15	0.79ââ±â0.15	NN	O
to	to	IN	O
0.21âÂ±â0.08âÂµmol	0.21âÂ±â0.08âÂµmol	NNS	O
/	/	SYM	O
min	min	NN	O
of	of	IN	O
modified	modify	VBN	O
infusion	infusion	NN	O
and	and	CC	O
no	no	DT	O
effect	effect	NN	O
on	on	IN	O
Km	Km	NNP	O
in	in	IN	O
the	the	DT	O
reaction	reaction	NN	O
catalysed	catalyse	VBN	O
by	by	IN	O
Î±-glucosidase	Î±-glucosidase	NNP	O
,	,	,	O
using	use	VBG	O
p	p	NN	O
-	-	HYPH	O
nitrophenyl	nitrophenyl	NN	O
-	-	HYPH	O
Î±-d	î±-d	NN	O
-	-	HYPH	O
glucopyranoside	glucopyranoside	NN	O
as	as	IN	O
the	the	DT	O
substrate	substrate	NN	O
,	,	,	O
compared	compare	VBN	O
to	to	IN	O
control	control	NN	O
.	.	.	O

In	in	IN	O
the	the	DT	O
assay	assay	NN	O
of	of	IN	O
pancreatic	pancreatic	JJ	O
lipase	lipase	NN	O
inhibitory	inhibitory	NN	O
activity	activity	NN	O
with	with	IN	O
p	p	NN	O
-	-	HYPH	O
nitrophenyl	nitrophenyl	NN	O
palmitate	palmitate	NN	O
as	as	IN	O
the	the	DT	O
substrate	substrate	NN	O
,	,	,	O
the	the	DT	O
presence	presence	NN	O
of	of	IN	O
modified	modify	VBN	O
chamomile	chamomile	NN	O
infusion	infusion	NN	O
at	at	IN	O
concentrations	concentration	NNS	O
of	of	IN	O
40âÂµM	40ââµm	CD	O
and	and	CC	O
60âÂµM	60ââµm	CD	O
decreased	decrease	VBD	O
the	the	DT	O
Vmax	Vmax	NNP	O
values	value	NNS	O
of	of	IN	O
1.97âÂ±â0.17	1.97âÂ±â0.17	NNS	O
to	to	IN	O
1.03âÂ±â0.04âÂµmol	1.03ââ±â0.04ââµmol	CD	O
/	/	SYM	O
min	min	NN	O
,	,	,	O
and	and	CC	O
increased	increase	VBD	O
the	the	DT	O
Km	Km	NNP	O
value	value	NN	O
to	to	IN	O
924.5	924.5	CD	O
and	and	CC	O
1107.3âmM	1107.3âmm	CD	O
,	,	,	O
respectively	respectively	RB	O
.	.	.	O

The	the	DT	O
results	result	NNS	O
were	be	VBD	O
analysed	analyse	VBN	O
by	by	IN	O
means	mean	NNS	O
of	of	IN	O
the	the	DT	O
LineweaverâBurk	lineweaverâburk	XX	O
double	double	JJ	O
reciprocal	reciprocal	JJ	O
plots	plot	NNS	O
and	and	CC	O
the	the	DT	O
Km	Km	NNP	O
and	and	CC	O
Vmax	Vmax	NNP	O
values	value	NNS	O
obtained	obtain	VBN	O
by	by	IN	O
graphic	graphic	JJ	O
extrapolation	extrapolation	NN	O
.	.	.	O

The	the	DT	O
double	double	JJ	O
reciprocal	reciprocal	JJ	O
graph	graph	NN	O
was	be	VBD	O
expressed	express	VBN	O
as	as	IN	O
1	1	CD	O
/	/	SYM	O
Vo	Vo	NNP	O
y	y	NNP	O
plotted	plot	VBD	O
against	against	IN	O
1/[S	1/[s	CD	O
,	,	,	O
where	where	WRB	O
the	the	DT	O
intercept	intercept	NN	O
on	on	IN	O
the	the	DT	O
1	1	CD	O
/	/	SYM	O
Vo	Vo	NNP	O
axis	axis	RB	O
is	be	VBZ	O
equal	equal	JJ	O
to	to	IN	O
1	1	CD	O
/	/	SYM	O
Vmax	Vmax	NNP	O
and	and	CC	O
the	the	DT	O
intercept	intercept	NN	O
on	on	IN	O
the	the	DT	O
1/[S	1/[s	CD	O
axis	axis	NNP	O
is	be	VBZ	O
equal	equal	JJ	O
to	to	IN	O
â1	â1	NN	O
/	/	NFP	O
Km	Km	NNP	O
Figure	Figure	NNP	O
2	2	CD	O
.	.	.	O

LineweaverâBurk	LineweaverâBurk	NNP	O
plot	plot	NN	O
of	of	IN	O
glucosidase	glucosidase	NN	O
A	a	NN	O
and	and	CC	O
pancreatic	pancreatic	JJ	O
lipase	lipase	NN	O
B	b	NN	O
activities	activity	NNS	O
.	.	.	O

V	V	NNP	O
is	be	VBZ	O
initial	initial	JJ	O
velocity	velocity	NN	O
and	and	CC	O
S	s	NN	O
is	be	VBZ	O
the	the	DT	O
concentration	concentration	NN	O
of	of	IN	O
substrate	substrate	NN	O
.	.	.	O

The	the	DT	O
values	value	NNS	O
were	be	VBD	O
shown	show	VBN	O
in	in	IN	O
absence	absence	NN	O
â	â	NNP	O
and	and	CC	O
presence	presence	NN	O
of	of	IN	O
enzymatically	enzymatically	RB	O
modified	modify	VBN	O
chamomile	chamomile	NN	O
infusion	infusion	NN	O
at	at	IN	O
40âÂµM	40ââµm	CD	O
â	â	NFP	O
and	and	CC	O
60âÂµM	60ââµm	CD	O
â²	â²	NNP	O
.	.	.	O

The	the	DT	O
values	value	NNS	O
are	be	VBP	O
means	mean	NNS	O
of	of	IN	O
triplicate	triplicate	NN	O
determinations	determination	NNS	O
,	,	,	O
and	and	CC	O
the	the	DT	O
error	error	NN	O
bars	bar	NNS	O
indicate	indicate	VBP	O
SD	SD	NNP	O
nâ=â3	nâ=â3	NNP	O
.	.	.	O

The	the	DT	O
alterations	alteration	NNS	O
of	of	IN	O
the	the	DT	O
kinetic	kinetic	JJ	O
parameters	parameter	NNS	O
suggested	suggest	VBD	O
two	two	CD	O
different	different	JJ	O
types	type	NNS	O
of	of	IN	O
inhibition	inhibition	NN	O
.	.	.	O

On	on	IN	O
the	the	DT	O
one	one	CD	O
hand	hand	NN	O
,	,	,	O
in	in	IN	O
the	the	DT	O
case	case	NN	O
of	of	IN	O
Î±-glucosidase	î±-glucosidase	NN	O
,	,	,	O
the	the	DT	O
enzymatic	enzymatic	JJ	O
inhibition	inhibition	NN	O
apparently	apparently	RB	O
is	be	VBZ	O
non	non	JJ	O
-	-	JJ	O
competitive	competitive	JJ	O
,	,	,	O
as	as	IN	O
we	-PRON-	PRP	O
can	can	MD	O
see	see	VB	O
a	a	DT	O
decrease	decrease	NN	O
in	in	IN	O
Vmax	Vmax	NNP	O
and	and	CC	O
no	no	DT	O
change	change	NN	O
in	in	IN	O
Km	Km	NNP	O
values	value	NNS	O
.	.	.	O

On	on	IN	O
the	the	DT	O
other	other	JJ	O
hand	hand	NN	O
,	,	,	O
in	in	IN	O
the	the	DT	O
pancreatic	pancreatic	JJ	O
lipase	lipase	NN	O
test	test	NN	O
,	,	,	O
a	a	DT	O
mixed	mixed	JJ	O
type	type	NN	O
of	of	IN	O
inhibition	inhibition	NN	O
seems	seem	VBZ	O
to	to	TO	O
occur	occur	VB	O
since	since	IN	O
the	the	DT	O
value	value	NN	O
of	of	IN	O
Vmax	Vmax	NNP	O
increased	increase	VBD	O
and	and	CC	O
Km	Km	NNP	O
value	value	NN	O
decreased	decrease	VBD	O
for	for	IN	O
both	both	CC	O
native	native	JJ	O
and	and	CC	O
enzymatically	enzymatically	RB	O
treated	treat	VBN	O
chamomile	chamomile	NN	O
infusion	infusion	NN	O
.	.	.	O

As	as	IN	O
hypothesised	hypothesise	VBN	O
,	,	,	O
enzymatic	enzymatic	JJ	O
processing	processing	NN	O
altered	alter	VBD	O
the	the	DT	O
chemical	chemical	NN	O
composition	composition	NN	O
and	and	CC	O
biological	biological	JJ	O
activity	activity	NN	O
of	of	IN	O
the	the	DT	O
chamomile	chamomile	NN	O
infusion	infusion	NN	O
.	.	.	O

It	-PRON-	PRP	O
is	be	VBZ	O
important	important	JJ	O
to	to	TO	O
emphasise	emphasise	VB	O
that	that	IN	O
the	the	DT	O
untargeted	untargeted	JJ	O
metabolomics	metabolomic	NNS	O
approach	approach	NN	O
used	use	VBN	O
here	here	RB	O
has	have	VBZ	O
the	the	DT	O
principal	principal	JJ	O
purpose	purpose	NN	O
of	of	IN	O
elucidating	elucidate	VBG	O
the	the	DT	O
main	main	JJ	O
statistically	statistically	RB	O
validated	validate	VBN	O
metabolites	metabolite	NNS	O
discriminating	discriminate	VBG	O
between	between	IN	O
chamomile	chamomile	NN	O
infusion	infusion	NN	O
and	and	CC	O
its	-PRON-	PRP$	O
hydrolysis	hydrolysis	NN	O
product	product	NN	O
rather	rather	RB	O
than	than	IN	O
providing	provide	VBG	O
some	some	DT	O
kind	kind	NN	O
of	of	IN	O
chemical	chemical	JJ	O
characterisation	characterisation	NN	O
of	of	IN	O
the	the	DT	O
native	native	JJ	O
chamomile	chamomile	NN	O
infusion	infusion	NN	O
.	.	.	O

The	the	DT	O
multicomponent	multicomponent	NN	O
chemical	chemical	NN	O
profile	profile	NN	O
of	of	IN	O
chamomile	chamomile	NN	O
flowers	flower	NNS	O
has	have	VBZ	O
been	be	VBN	O
demonstrated	demonstrate	VBN	O
previously	previously	RB	B
.	.	.	O

The	the	DT	O
main	main	JJ	O
related	related	JJ	O
constituents	constituent	NNS	O
are	be	VBP	O
cosmosiin	cosmosiin	NN	O
apigenin-7-O	apigenin-7-o	NN	O
-	-	HYPH	O
glucopyranoside	glucopyranoside	NN	O
and	and	CC	O
its	-PRON-	PRP$	O
derivatives	derivative	NNS	O
apigenin-7-O-(4â³-	apigenin-7-O-(4â³-	NNP	O
malonyl)-glucopyranoside	malonyl)-glucopyranoside	NNP	O
,	,	,	O
apigenin-7-O-(6â³-malonyl)-glucopyranoside	apigenin-7-o-(6â³-malonyl)-glucopyranoside	CD	O
,	,	,	O
apigenin-7-O-(4â³-acetyl)-glucopyranoside	apigenin-7-o-(4â³-acetyl)-glucopyranoside	CD	O
,	,	,	O
apigenin-7-O-(4â³-malonyl-6â³-acetyl)-glucopyranoside	apigenin-7-o-(4â³-malonyl-6â³-acetyl)-glucopyranoside	NN	O
,	,	,	O
phenylpropanoids	phenylpropanoid	NNS	O
3-O-	3-o-	CD	O
and	and	CC	O
3,5-di	3,5-di	CD	O
-	-	HYPH	O
O	o	NN	O
-	-	HYPH	O
caffeoylquinic	caffeoylquinic	JJ	O
acids	acid	NNS	O
,	,	,	O
2-O	2-o	CD	O
-	-	HYPH	O
glucopyranosides	glucopyranoside	NNS	O
of	of	IN	O
cis-	cis-	NN	O
and	and	CC	O
trans-2-hydroxy-4-methoxycoumaric	trans-2-hydroxy-4-methoxycoumaric	JJ	O
acid	acid	NN	O
,	,	,	O
coumarins	coumarins	NNP	O
skimmin	skimmin	NNP	O
,	,	,	O
daphnetin	daphnetin	NNP	O
,	,	,	O
daphnin	daphnin	NNP	O
,	,	,	O
umbelliferone	umbelliferone	NNP	O
,	,	,	O
herniarin	herniarin	NNP	O
,	,	,	O
as	as	RB	O
well	well	RB	O
as	as	IN	O
terpenes	terpene	NNS	O
cis-	cis-	JJ	O
and	and	CC	O
trans	trans	NNP	O
-	-	HYPH	O
spiro	spiro	NNP	O
-	-	HYPH	O
ether	ether	NN	O
.	.	.	O

Both	both	DT	O
flavonoid	flavonoid	NN	O
and	and	CC	O
non	non	JJ	O
-	-	JJ	O
flavonoid	flavonoid	JJ	O
polyphenols	polyphenol	NNS	O
were	be	VBD	O
significantly	significantly	RB	O
altered	alter	VBN	O
by	by	IN	O
the	the	DT	O
acidic	acidic	JJ	O
enzymatic	enzymatic	JJ	O
treatment	treatment	NN	O
which	which	WDT	O
resulted	result	VBD	O
in	in	IN	O
the	the	DT	O
favourable	favourable	JJ	O
action	action	NN	O
of	of	IN	O
metabolites	metabolite	NNS	O
as	as	IN	O
inhibitors	inhibitor	NNS	O
of	of	IN	O
digestive	digestive	JJ	O
enzymes	enzyme	NNS	O
,	,	,	O
in	in	IN	O
particular	particular	JJ	O
as	as	IN	O
inhibitors	inhibitor	NNS	O
of	of	IN	O
pancreatic	pancreatic	JJ	O
lipase	lipase	NN	O
activity	activity	NN	O
.	.	.	O

A	a	DT	O
significant	significant	JJ	O
effect	effect	NN	O
was	be	VBD	O
also	also	RB	O
observed	observe	VBN	O
on	on	IN	O
glucosidase	glucosidase	NN	O
inhibition	inhibition	NN	O
.	.	.	O

It	-PRON-	PRP	O
has	have	VBZ	O
been	be	VBN	O
reported	report	VBN	O
that	that	IN	O
some	some	DT	O
polyphenols	polyphenol	NNS	O
may	may	MD	O
inhibit	inhibit	VB	O
digestive	digestive	JJ	O
enzymes	enzyme	NNS	O
involved	involve	VBN	O
in	in	IN	O
the	the	DT	O
breakdown	breakdown	NN	O
of	of	IN	O
starches	starch	NNS	O
and	and	CC	O
lipids	lipid	NNS	O
,	,	,	O
leading	lead	VBG	O
to	to	IN	O
a	a	DT	O
reduction	reduction	NN	O
in	in	IN	O
glucose	glucose	NN	O
and	and	CC	O
lipid	lipid	NN	O
absorption	absorption	NN	O
and	and	CC	O
therefore	therefore	RB	O
to	to	IN	O
positive	positive	JJ	O
effects	effect	NNS	O
on	on	IN	O
obesity	obesity	NN	O
and	and	CC	O
blood	blood	NN	O
glucose	glucose	NN	O
control	control	NN	O
,	,	,	O
which	which	WDT	O
is	be	VBZ	O
an	an	DT	O
effective	effective	JJ	O
strategy	strategy	NN	O
for	for	IN	O
type	type	NN	O
2	2	CD	O
diabetes	diabetes	NN	O
prevention	prevention	NN	O
and	and	CC	O
treatment	treatment	NN	B
.	.	.	O

Based	base	VBN	O
on	on	IN	O
the	the	DT	O
results	result	NNS	O
obtained	obtain	VBN	O
from	from	IN	O
UPLC	UPLC	NNP	O
-	-	HYPH	O
QTOF	QTOF	NNP	O
-	-	HYPH	O
MSE	MSE	NNP	O
analysis	analysis	NN	O
,	,	,	O
it	-PRON-	PRP	O
could	could	MD	O
be	be	VB	O
seen	see	VBN	O
that	that	IN	O
the	the	DT	O
enzymatic	enzymatic	JJ	O
hydrolysis	hydrolysis	NN	O
reaction	reaction	NN	O
of	of	IN	O
polyphenol	polyphenol	NN	O
compounds	compound	NNS	O
in	in	IN	O
the	the	DT	O
infusion	infusion	NN	O
by	by	IN	O
a	a	DT	O
combination	combination	NN	O
of	of	IN	O
glycosyl	glycosyl	JJ	O
hydrolases	hydrolases	NNP	O
hesperidinase	hesperidinase	NNP	O
and	and	CC	O
galactosidase	galactosidase	NNP	O
led	lead	VBD	O
to	to	IN	O
the	the	DT	O
increase	increase	NN	O
of	of	IN	O
aglycone	aglycone	JJ	O
flavonoid	flavonoid	NN	O
levels	level	NNS	O
and	and	CC	O
of	of	IN	O
hydroxylated	hydroxylate	VBN	O
phenolic	phenolic	JJ	O
acids	acid	NNS	O
.	.	.	O

Derivatives	derivative	NNS	O
of	of	IN	O
cinnamic	cinnamic	JJ	O
acids	acid	NNS	O
2-hydroxy	2-hydroxy	CD	O
cinnamic	cinnamic	NN	O
,	,	,	O
3,4-dihydroxycinnamic	3,4-dihydroxycinnamic	JJ	O
acid	acid	NN	O
and	and	CC	O
4-hydroxy-3,5-dimethoxycinnamic	4-hydroxy-3,5-dimethoxycinnamic	CD	O
acids	acid	NNS	O
and	and	CC	O
of	of	IN	O
benzoic	benzoic	JJ	O
acids	acid	NNS	O
di	di	NNP	O
and	and	CC	O
trihydroxybenzoic	trihydroxybenzoic	NNP	O
acids	acid	NNS	O
tended	tend	VBD	O
to	to	TO	O
increase	increase	VB	O
after	after	IN	O
enzymatic	enzymatic	JJ	O
treatment	treatment	NN	O
compared	compare	VBN	O
to	to	IN	O
their	-PRON-	PRP$	O
contents	content	NNS	O
in	in	IN	O
native	native	JJ	O
infusion	infusion	NN	O
.	.	.	O

Cinnamic	cinnamic	JJ	O
acids	acid	NNS	O
,	,	,	O
especially	especially	RB	O
those	those	DT	O
with	with	IN	O
the	the	DT	O
phenolic	phenolic	NNP	O
hydroxyl	hydroxyl	NNP	O
group	group	NNP	O
,	,	,	O
are	be	VBP	O
well	well	RB	O
-	-	HYPH	O
known	know	VBN	O
antioxidants	antioxidant	NNS	O
and	and	CC	O
are	be	VBP	O
supposed	suppose	VBN	O
to	to	TO	O
have	have	VB	O
several	several	JJ	O
health	health	NN	O
benefits	benefit	NNS	O
due	due	JJ	O
to	to	IN	O
their	-PRON-	PRP$	O
strong	strong	JJ	O
free	free	JJ	O
radical	radical	JJ	O
scavenging	scavenging	JJ	O
properties	property	NNS	B
.	.	.	O

Chlorogenic	chlorogenic	JJ	O
acid	acid	NN	O
,	,	,	O
the	the	DT	O
major	major	JJ	O
representative	representative	NN	O
of	of	IN	O
hydroxycinnamic	hydroxycinnamic	JJ	O
acids	acid	NNS	O
,	,	,	O
is	be	VBZ	O
an	an	DT	O
ester	ester	NN	O
formed	form	VBN	O
between	between	IN	O
quinic	quinic	JJ	O
acid	acid	NN	O
and	and	CC	O
caffeic	caffeic	NN	O
acid	acid	NN	O
3,4-dihydroxycinnamic	3,4-dihydroxycinnamic	JJ	O
acid	acid	NN	O
and	and	CC	O
it	-PRON-	PRP	O
has	have	VBZ	O
been	be	VBN	O
reported	report	VBN	O
that	that	IN	O
caffeic	caffeic	NN	O
acid	acid	NN	O
has	have	VBZ	O
stronger	strong	JJR	O
inÂ	inÂ	NNP	O
vitro	vitro	FW	O
antioxidant	antioxidant	JJ	O
activity	activity	NN	O
than	than	IN	O
that	that	DT	O
of	of	IN	O
chlorogenic	chlorogenic	JJ	O
acid	acid	NN	B
,	,	,	O
which	which	WDT	O
might	may	MD	O
contribute	contribute	VB	O
to	to	IN	O
the	the	DT	O
increased	increase	VBN	O
antioxidant	antioxidant	JJ	O
activity	activity	NN	O
of	of	IN	O
the	the	DT	O
modified	modify	VBN	O
infusion	infusion	NN	O
.	.	.	O

The	the	DT	O
observed	observed	JJ	O
significant	significant	JJ	O
increase	increase	NN	O
of	of	IN	O
esculetin	esculetin	NN	O
,	,	,	O
luteolin	luteolin	NNP	O
and	and	CC	O
apigenin	apigenin	JJ	O
aglycones	aglycone	NNS	O
in	in	IN	O
the	the	DT	O
treated	treated	JJ	O
infusion	infusion	NN	O
suggest	suggest	VBP	O
that	that	IN	O
the	the	DT	O
hesperidinase	hesperidinase	NN	O
was	be	VBD	O
able	able	JJ	O
to	to	TO	O
remove	remove	VB	O
glucose	glucose	NN	O
from	from	IN	O
esculin	esculin	NNP	O
esculetin	esculetin	NNP	O
6-O	6-o	CD	O
-	-	HYPH	O
glucoside	glucoside	NN	O
,	,	,	O
luteoloside	luteoloside	VB	O
luteolin	luteolin	NNP	O
7-O	7-o	CD	O
-	-	HYPH	O
glucoside	glucoside	NN	O
,	,	,	O
and	and	CC	O
apigenin	apigenin	JJ	O
derivatives	derivative	NNS	O
apigenin-7-O	apigenin-7-o	NN	O
-	-	HYPH	O
glucoside	glucoside	NN	O
and	and	CC	O
apigenin-7-apioglucoside	apigenin-7-apioglucoside	NNP	O
.	.	.	O

Incubation	incubation	NN	O
with	with	IN	O
the	the	DT	O
enzyme	enzyme	NNS	O
combination	combination	NN	O
enabled	enable	VBD	O
efficient	efficient	JJ	O
hydrolysis	hydrolysis	NN	O
of	of	IN	O
rutinosides	rutinoside	NNS	O
and	and	CC	O
hesperidoside	hesperidoside	NN	O
from	from	IN	O
diosmin	diosmin	NN	O
,	,	,	O
quercetin	quercetin	NNP	O
and	and	CC	O
kaempferol	kaempferol	VB	O
.	.	.	O

The	the	DT	O
DPPHâ¢	DPPHâ¢	NNP	O
scavenging	scavenge	VBG	O
activity	activity	NN	O
of	of	IN	O
chamomile	chamomile	JJ	O
aqueous	aqueous	JJ	O
infusion	infusion	NN	O
can	can	MD	O
be	be	VB	O
attributed	attribute	VBN	O
in	in	IN	O
part	part	NN	O
to	to	IN	O
flavonoids	flavonoid	NNS	O
and	and	CC	O
possibly	possibly	RB	O
to	to	IN	O
some	some	DT	O
other	other	JJ	O
polyphenols	polyphenol	NNS	O
with	with	IN	O
low	low	JJ	O
molecular	molecular	JJ	O
weights	weight	NNS	O
.	.	.	O

Apigenin	Apigenin	NNP	O
,	,	,	O
the	the	DT	O
most	most	RBS	O
abundant	abundant	JJ	O
flavenoid	flavenoid	NN	O
,	,	,	O
is	be	VBZ	O
recognised	recognise	VBN	O
as	as	IN	O
one	one	CD	O
of	of	IN	O
the	the	DT	O
most	most	RBS	O
bioactive	bioactive	JJ	O
phenolic	phenolic	JJ	O
compounds	compound	NNS	O
in	in	IN	O
chamomile	chamomile	NN	O
.	.	.	O

In	in	IN	O
comparison	comparison	NN	O
to	to	IN	O
its	-PRON-	PRP$	O
bound	bind	VBN	O
forms	form	NNS	O
,	,	,	O
which	which	WDT	O
include	include	VBP	O
mostly	mostly	RB	O
apigenin-7-O	apigenin-7-O	NNP	O
-	-	HYPH	O
Î²-glucoside	î²-glucoside	NN	O
and	and	CC	O
various	various	JJ	O
acylated	acylate	VBN	O
forms	form	NNS	O
,	,	,	O
the	the	DT	O
aglycone	aglycone	NN	O
is	be	VBZ	O
endowed	endow	VBN	O
with	with	IN	O
much	much	RB	O
higher	high	JJR	O
bioactivity	bioactivity	NN	O
.	.	.	O

Li	Li	NNP	O
etÂ	etÂ	NNP	O
al	al	NNP	O
.	.	.	B
showed	show	VBD	O
that	that	IN	O
inhibitory	inhibitory	JJ	O
abilities	ability	NNS	O
of	of	IN	O
individual	individual	JJ	O
flavonoids	flavonoid	NNS	O
against	against	IN	O
amylase	amylase	NN	O
and	and	CC	O
glucosidase	glucosidase	NN	O
were	be	VBD	O
in	in	IN	O
exactly	exactly	RB	O
the	the	DT	O
same	same	JJ	O
sequence	sequence	NN	O
apigeninâ>âbaicaleinâ>âscutellarinâ>âchrysinâ>âapigenin-7-O	apigeninâ>âbaicaleinâ>âscutellarinâ>âchrysinâ>âapigenin-7-O	NNP	O
-	-	HYPH	O
glucuronideâ>âbaicalinâ>âchrysin-7-O	glucuronideâ>âbaicalinâ>âchrysin-7-O	NNP	O
-	-	HYPH	O
glucuronideâ>âisocarthamidin-7-O	glucuronideâ>âisocarthamidin-7-o	NN	O
-	-	HYPH	O
glucuronide	glucuronide	NNP	O
.	.	.	O

The	the	DT	O
apigenin	apigenin	NN	O
possessed	possess	VBD	O
the	the	DT	O
strongest	strong	JJS	O
enzyme	enzyme	NNS	O
inhibitory	inhibitory	JJ	O
effect	effect	NN	O
which	which	WDT	O
was	be	VBD	O
attributed	attribute	VBN	O
to	to	IN	O
seven	seven	CD	O
double	double	JJ	O
bonds	bond	NNS	O
in	in	IN	O
the	the	DT	O
two	two	CD	O
aromatic	aromatic	JJ	O
rings	ring	NNS	O
and	and	CC	O
hydroxyls	hydroxyls	JJ	O
present	present	NN	O
on	on	IN	O
C-7	C-7	NNP	O
and	and	CC	O
C-4â²	c-4â²	NN	O
of	of	IN	O
ring	ring	NNP	O
B.	B.	NNP	O
Isoquercetin	Isoquercetin	NNP	O
showed	show	VBD	O
Î±-glucosidase	î±-glucosidase	NN	O
inhibition	inhibition	NN	O
toward	toward	IN	O
maltase	maltase	NN	O
and	and	CC	O
sucrase	sucrase	NN	O
with	with	IN	O
IC50	IC50	NNP	O
values	value	NNS	O
of	of	IN	O
64.1	64.1	CD	O
and	and	CC	O
42.5âÂµM	42.5ââµm	CD	O
,	,	,	O
respectively	respectively	RB	O
,	,	,	O
which	which	WDT	O
were	be	VBD	O
10	10	CD	O
and	and	CC	O
5	5	CD	O
times	time	NNS	O
,	,	,	O
respectively	respectively	RB	O
,	,	,	O
more	more	RBR	O
potent	potent	JJ	O
than	than	IN	O
its	-PRON-	PRP$	O
corresponding	corresponding	JJ	O
diglucoside	diglucoside	NN	O
quercetin-3-O	quercetin-3-O	NNP	O
-	-	HYPH	O
Î²-glucopyranosyl	î²-glucopyranosyl	NN	O
-	-	HYPH	O
glucoside	glucoside	NN	O
.	.	.	O

This	this	DT	O
observation	observation	NN	O
suggested	suggest	VBD	O
that	that	IN	O
the	the	DT	O
increase	increase	NN	O
in	in	IN	O
hydrophilicity	hydrophilicity	NN	O
by	by	IN	O
the	the	DT	O
extra	extra	JJ	O
glucose	glucose	NN	O
moiety	moiety	NN	O
in	in	IN	O
glycosylated	glycosylated	JJ	O
quercetin	quercetin	NNP	O
dramatically	dramatically	RB	O
reduced	reduce	VBD	O
the	the	DT	O
inhibitory	inhibitory	JJ	O
effect	effect	NN	B
.	.	.	O

Another	another	DT	O
report	report	NN	O
by	by	IN	O
Zhang	Zhang	NNP	O
etÂ	etÂ	NNP	O
al	al	NNP	O
.	.	.	B
pointed	point	VBD	O
to	to	IN	O
the	the	DT	O
flavonols	flavonol	NNS	O
including	include	VBG	O
kaempferol	kaempferol	NNP	O
and	and	CC	O
quercetin	quercetin	NNP	O
glycoside	glycoside	NN	O
,	,	,	O
but	but	CC	O
not	not	RB	O
the	the	DT	O
flavanols	flavanol	NNS	O
including	include	VBG	O
catechin	catechin	NN	O
/	/	SYM	O
epicatechin	epicatechin	NN	O
-	-	HYPH	O
glucoside	glucoside	NN	O
and	and	CC	O
procyanidin	procyanidin	NNP	O
dimer	dimer	NN	O
,	,	,	O
as	as	IN	O
the	the	DT	O
most	most	RBS	O
important	important	JJ	O
contributors	contributor	NNS	O
to	to	IN	O
the	the	DT	O
inhibitory	inhibitory	JJ	O
activities	activity	NNS	O
against	against	IN	O
Î±-glucosidase	î±-glucosidase	NN	O
and	and	CC	O
pancreatic	pancreatic	JJ	O
lipase	lipase	NN	O
.	.	.	O

Interestingly	interestingly	RB	O
,	,	,	O
and	and	CC	O
more	more	JJR	O
against	against	IN	O
the	the	DT	O
latter	latter	JJ	O
,	,	,	O
the	the	DT	O
Galloyl	Galloyl	NNP	O
moiety	moiety	NN	O
of	of	IN	O
the	the	DT	O
flavanols	flavanol	NNS	O
has	have	VBZ	O
been	be	VBN	O
considered	consider	VBN	O
as	as	IN	O
a	a	DT	O
prerequisite	prerequisite	JJ	O
feature	feature	NN	O
for	for	IN	O
the	the	DT	O
lipase	lipase	NN	O
inhibition	inhibition	NN	B
.	.	.	O

In	in	IN	O
a	a	DT	O
recent	recent	JJ	O
study	study	NN	O
,	,	,	O
the	the	DT	O
ethanolic	ethanolic	JJ	O
extract	extract	NN	O
of	of	IN	O
Chamomilla	Chamomilla	NNP	O
recutita	recutita	NNS	O
inhibited	inhibited	JJ	O
lipase	lipase	NN	O
activity	activity	NN	O
86.6âÂ±â0.3	86.6ââ±â0.3	CD	O
%	%	NN	O
in	in	IN	O
addition	addition	NN	O
to	to	IN	O
having	have	VBG	O
high	high	JJ	O
antioxidant	antioxidant	NN	O
and	and	CC	O
anti	anti	JJ	O
-	-	JJ	O
glycation	glycation	JJ	O
capacities	capacity	NNS	B
.	.	.	O

While	while	IN	O
EC50	ec50	NN	O

values	value	NNS	O
have	have	VBP	O
shown	show	VBN	O
the	the	DT	O
potency	potency	NN	O
of	of	IN	O
the	the	DT	O
natural	natural	JJ	O
compound	compound	NN	O
,	,	,	O
more	more	RBR	O
valuable	valuable	JJ	O
information	information	NN	O
can	can	MD	O
be	be	VB	O
obtained	obtain	VBN	O
from	from	IN	O
the	the	DT	O
kinetics	kinetic	NNS	O
of	of	IN	O
inhibition	inhibition	NN	O
by	by	IN	O
individual	individual	JJ	O
compounds	compound	NNS	O
or	or	CC	O
a	a	DT	O
mixture	mixture	NN	O
of	of	IN	O
compounds	compound	NNS	O
from	from	IN	O
the	the	DT	O
natural	natural	JJ	O
extract	extract	NN	O
.	.	.	O

The	the	DT	O
components	component	NNS	O
of	of	IN	O
chamomile	chamomile	NN	O
showed	show	VBD	O
a	a	DT	O
non	non	JJ	O
-	-	JJ	O
competitive	competitive	JJ	O
inhibition	inhibition	NN	O
on	on	IN	O
glucosidase	glucosidase	NN	O
activity	activity	NN	O
and	and	CC	O
a	a	DT	O
mixed	mixed	JJ	O
inhibition	inhibition	NN	O
on	on	IN	O
lipase	lipase	NN	O
activity	activity	NN	O
Figure	Figure	NNP	O
2	2	CD	O
.	.	.	O

When	when	WRB	O
an	an	DT	O
inhibitor	inhibitor	NN	O
binds	bind	VBZ	O
to	to	IN	O
the	the	DT	O
enzyme	enzyme	NNS	O
and/or	and/or	CC	O
enzymeâsubstrate	enzymeâsubstrate	NNP	O
ES	ES	NNP	O
complex	complex	NN	O
it	-PRON-	PRP	O
is	be	VBZ	O
defined	define	VBN	O
as	as	IN	O
non	non	JJ	O
-	-	JJ	O
competitive	competitive	JJ	O
inhibition	inhibition	NN	O
,	,	,	O
in	in	IN	O
which	which	WDT	O
the	the	DT	O
inhibitor	inhibitor	NN	O
affects	affect	VBZ	O
only	only	RB	O
Vmax	Vmax	NNP	O
of	of	IN	O
the	the	DT	O
reaction	reaction	NN	O
,	,	,	O
but	but	CC	O
has	have	VBZ	O
no	no	DT	O
effect	effect	NN	O
on	on	IN	O
ES	ES	NNP	O
complex	complex	JJ	O
formation	formation	NN	O
.	.	.	O

Mixed	mixed	JJ	O
inhibition	inhibition	NN	O
occurs	occur	VBZ	O
when	when	WRB	O
the	the	DT	O
inhibitor	inhibitor	NN	O
binds	bind	VBZ	O
at	at	IN	O
a	a	DT	O
distinct	distinct	JJ	O
site	site	NN	O
from	from	IN	O
the	the	DT	O
active	active	JJ	O
site	site	NN	O
,	,	,	O
but	but	CC	O
with	with	IN	O
simultaneous	simultaneous	JJ	O
formation	formation	NN	O
of	of	IN	O
an	an	DT	O
enzymeâinhibitor	enzymeâinhibitor	NNP	O
EI	EI	NNP	O
complex	complex	NN	O
in	in	IN	O
a	a	DT	O
competitive	competitive	JJ	O
manner	manner	NN	O
and	and	CC	O
an	an	DT	O
enzymeâsubstrateâinhibitor	enzymeâsubstrateâinhibitor	FW	O
ESI	ESI	NNP	O
complex	complex	NN	O
in	in	IN	O
a	a	DT	O
non	non	JJ	O
-	-	JJ	O
competitive	competitive	JJ	O
way	way	NN	O
.	.	.	O

Probably	probably	RB	O
this	this	DT	O
result	result	NN	O
was	be	VBD	O
due	due	JJ	O
to	to	IN	O
the	the	DT	O
mixture	mixture	NN	O
of	of	IN	O
compounds	compound	NNS	O
found	find	VBN	O
in	in	IN	O
the	the	DT	O
chamomile	chamomile	NN	O
infusion	infusion	NN	O
containing	contain	VBG	O
compounds	compound	NNS	O
with	with	IN	O
both	both	DT	O
types	type	NNS	O
of	of	IN	O
inhibition	inhibition	NN	O
,	,	,	O
as	as	RB	O
well	well	RB	O
as	as	IN	O
the	the	DT	O
high	high	JJ	O
efficiency	efficiency	NN	O
of	of	IN	O
the	the	DT	O
bioconversion	bioconversion	NN	O
reaction	reaction	NN	O
,	,	,	O
which	which	WDT	O
led	lead	VBD	O
to	to	IN	O
the	the	DT	O
conversion	conversion	NN	O
of	of	IN	O
active	active	JJ	O
compounds	compound	NNS	O
to	to	TO	O
even	even	RB	O
more	more	RBR	O
active	active	JJ	O
metabolites	metabolite	NNS	O
that	that	WDT	O
can	can	MD	O
act	act	VB	O
as	as	IN	O
enzyme	enzyme	NNS	O
inhibitors	inhibitor	NNS	O
.	.	.	O

Gholamhoseinian	gholamhoseinian	JJ	O
etÂ	etÂ	NNP	O
al	al	NNP	O
.	.	.	B
found	find	VBD	O
similar	similar	JJ	O
results	result	NNS	O
showing	show	VBG	O
that	that	IN	O
components	component	NNS	O
of	of	IN	O
Levisticum	levisticum	JJ	O
officinale	officinale	NN	O
can	can	MD	O
bind	bind	VB	O
to	to	IN	O
the	the	DT	O
enzyme	enzyme	NNS	O
or	or	CC	O
ES	es	NN	O
complex	complex	NN	O
,	,	,	O
blocking	block	VBG	O
the	the	DT	O
pancreatic	pancreatic	JJ	O
lipase	lipase	NN	O
activity	activity	NN	O
.	.	.	O

Though	though	IN	O
a	a	DT	O
number	number	NN	O
of	of	IN	O
polyphenols	polyphenol	NNS	O
have	have	VBP	O
been	be	VBN	O
reported	report	VBN	O
as	as	IN	O
inhibitory	inhibitory	NN	O
to	to	IN	O
the	the	DT	O
action	action	NN	O
of	of	IN	O
digestive	digestive	JJ	O
enzymes	enzyme	NNS	O
inÂ	inÂ	NNP	O
vitro	vitro	FW	O
,	,	,	O
only	only	RB	O
a	a	DT	O
limited	limited	JJ	O
number	number	NN	O
of	of	IN	O
reports	report	NNS	O
have	have	VBP	O
diagnosed	diagnose	VBN	O
their	-PRON-	PRP$	O
mode	mode	NN	O
of	of	IN	O
inhibition	inhibition	NN	O
,	,	,	O
showing	show	VBG	O
,	,	,	O
however	however	RB	O
,	,	,	O
contradictory	contradictory	JJ	O
results	result	NNS	O
.	.	.	O

For	for	IN	O
instance	instance	NN	O
,	,	,	O
phenolics	phenolic	NNS	O
from	from	IN	O
the	the	DT	O
methanolic	methanolic	JJ	O
extract	extract	NN	O
of	of	IN	O
finger	finger	NNP	O
millet	millet	NNP	O
seed	seed	NNP	O
coat	coat	NN	O
showed	show	VBD	O
strong	strong	JJ	O
inhibition	inhibition	NN	O
towards	towards	IN	O
glucosidase	glucosidase	NN	O
and	and	CC	O
pancreatic	pancreatic	JJ	O
amylase	amylase	NN	O
with	with	IN	O
non	non	JJ	O
-	-	JJ	O
competitive	competitive	JJ	O
inhibition	inhibition	NN	B
,	,	,	O
while	while	IN	O
phenolic	phenolic	JJ	O
acids	acid	NNS	O
from	from	IN	O
potato	potato	NN	O
cultivars	cultivar	NNS	O
acted	act	VBD	O
as	as	IN	O
effective	effective	JJ	O
mixed	mix	VBN	O
inhibitors	inhibitor	NNS	O
for	for	IN	O
Î±-amylase	Î±-amylase	NNP	O
and	and	CC	O
Î±-glucosidase	î±-glucosidase	NN	O
and	and	CC	O
non	non	JJ	O
-	-	JJ	O
competitive	competitive	JJ	O
inhibitors	inhibitor	NNS	O
for	for	IN	O
aldose	aldose	JJ	O
reductase	reductase	NN	B
.	.	.	O

Main	main	JJ	O
polyphenols	polyphenol	NNS	O
in	in	IN	O
yerba	yerba	NNP	O
matÃ	matÃ	NNP	O
©	©	RB	O
chlorogenic	chlorogenic	JJ	O
acids	acid	NNS	O
,	,	,	O
caffeoylquinic	caffeoylquinic	JJ	O
acids	acid	NNS	O
,	,	,	O
dicaffeoylquinic	dicaffeoylquinic	JJ	O
acids	acid	NNS	O
competitively	competitively	RB	O
inhibited	inhibit	VBD	O
pancreatic	pancreatic	JJ	O
lipase	lipase	NN	O
activity	activity	NN	O
in	in	IN	O
a	a	DT	O
concentration	concentration	NN	O
-	-	HYPH	O
dependent	dependent	JJ	O
manner	manner	NN	O
with	with	IN	O
an	an	DT	O
IC50	IC50	NNP	O
value	value	NN	O
of	of	IN	O
1.5âmg	1.5âmg	CD	O
MT	MT	NNP	O
/	/	SYM	O
ml	ml	NN	B
.	.	.	O

Such	such	PDT	O
a	a	DT	O
variation	variation	NN	O
in	in	IN	O
inhibitor	inhibitor	NN	O
potency	potency	NN	O
,	,	,	O
as	as	RB	O
well	well	RB	O
as	as	IN	O
the	the	DT	O
mode	mode	NN	O
of	of	IN	O
enzyme	enzyme	NNS	O
inhibition	inhibition	NN	O
,	,	,	O
is	be	VBZ	O
not	not	RB	O
unusual	unusual	JJ	O
since	since	IN	O
the	the	DT	O
inhibitor	inhibitor	NN	O
potency	potency	NN	O
of	of	IN	O
polyphenolic	polyphenolic	JJ	O
compounds	compound	NNS	O
depends	depend	VBZ	O
on	on	IN	O
several	several	JJ	O
factors	factor	NNS	O
,	,	,	O
such	such	JJ	O
as	as	IN	O
the	the	DT	O
structure	structure	NN	O
and	and	CC	O
stability	stability	NN	O
of	of	IN	O
the	the	DT	O
inhibitors	inhibitor	NNS	O
.	.	.	O

That	that	DT	O
finding	finding	NN	O
is	be	VBZ	O
in	in	IN	O
agreement	agreement	NN	O
with	with	IN	O
an	an	DT	O
earlier	early	JJR	O
study	study	NN	O
that	that	WDT	O
showed	show	VBD	O
the	the	DT	O
inhibitory	inhibitory	JJ	O
effect	effect	NN	O
of	of	IN	O
flavonoids	flavonoid	NNS	O
on	on	IN	O
pancreatic	pancreatic	JJ	O
lipase	lipase	NN	O
activity	activity	NN	O
and	and	CC	O
reported	report	VBD	O
that	that	IN	O
the	the	DT	O
presence	presence	NN	O
of	of	IN	O
sugar	sugar	NN	O
units	unit	NNS	O
in	in	IN	O
flavonoid	flavonoid	JJ	O
structures	structure	NNS	O
reduces	reduce	VBZ	O
their	-PRON-	PRP$	O
inhibitory	inhibitory	JJ	O
power	power	NN	O
so	so	IN	O
that	that	IN	O
an	an	DT	O
aglycone	aglycone	NN	O
form	form	NN	O
,	,	,	O
such	such	JJ	O
as	as	IN	O
quercetin	quercetin	NNP	O
,	,	,	O
is	be	VBZ	O
a	a	DT	O
more	more	RBR	O
efficient	efficient	JJ	O
inhibitor	inhibitor	NN	O
than	than	IN	O
the	the	DT	O
glycosylated	glycosylate	VBN	O
form	form	NN	O
,	,	,	O
rutin	rutin	VBZ	B
.	.	.	O

Sergent	sergent	JJ	O
etÂ	etÂ	NNP	O
al	al	NNP	O
.	.	.	B
also	also	RB	O
reported	report	VBD	O
that	that	IN	O
the	the	DT	O
phenolic	phenolic	JJ	O
compounds	compound	NNS	O
,	,	,	O
including	include	VBG	O
quercetin	quercetin	NNP	O
and	and	CC	O
kaempferol	kaempferol	NN	O
,	,	,	O
exerted	exert	VBD	O
strong	strong	JJ	O
inhibitory	inhibitory	JJ	O
activity	activity	NN	O
on	on	IN	O
pancreatic	pancreatic	JJ	O
lipase	lipase	NN	O
.	.	.	O

Km	Km	VBG	O
values	value	NNS	O
for	for	IN	O
pancreatic	pancreatic	JJ	O
lipase	lipase	NN	O
inhibition	inhibition	NN	O
by	by	IN	O
quercetin	quercetin	NNP	O
were	be	VBD	O
previously	previously	RB	O
reported	report	VBN	O
and	and	CC	O
varied	vary	VBN	O
from	from	IN	O
2.15âÂ±â0.40âÂµM	2.15ââ±â0.40ââµm	CD	B
to	to	IN	O
10âÂµM	10ââµm	CD	B
.	.	.	O

It	-PRON-	PRP	O
is	be	VBZ	O
difficult	difficult	JJ	O
to	to	TO	O
establish	establish	VB	O
comparisons	comparison	NNS	O
between	between	IN	O
the	the	DT	O
results	result	NNS	O
reported	report	VBN	O
by	by	IN	O
the	the	DT	O
above	above	JJ	O
authors	author	NNS	O
,	,	,	O
since	since	IN	O
they	-PRON-	PRP	O
were	be	VBD	O
determined	determine	VBN	O
with	with	IN	O
different	different	JJ	O
substrates	substrate	NNS	O
/	/	SYM	O
flavonoids	flavonoid	NNS	O
as	as	RB	O
well	well	RB	O
as	as	IN	O
under	under	IN	O
different	different	JJ	O
conditions	condition	NNS	O
of	of	IN	O
temperature	temperature	NN	O
and	and	CC	O
pH.	pH.	NNP	O
On	on	IN	O
the	the	DT	O
other	other	JJ	O
hand	hand	NN	O
,	,	,	O
Zhang	Zhang	NNP	O
etÂ	etÂ	NNP	O
al	al	NNP	O
.	.	.	B
analysed	analyse	VBD	O
the	the	DT	O
difference	difference	NN	O
between	between	IN	O
flavonol	flavonol	NN	O
glycosides	glycoside	NNS	O
and	and	CC	O
their	-PRON-	PRP$	O
aglycones	aglycone	NNS	O
from	from	IN	O
lentil	lentil	NNP	O
Lens	Lens	NNP	O
cultivars	cultivar	NNS	O
cultivar	cultivar	VBP	O
extracts	extract	NNS	O
against	against	IN	O
pancreatic	pancreatic	JJ	O
lipase	lipase	NN	O
activity	activity	NN	O
,	,	,	O
and	and	CC	O
they	-PRON-	PRP	O
did	do	VBD	O
not	not	RB	O
find	find	VB	O
statistically	statistically	RB	O
different	different	JJ	O
values	value	NNS	O
for	for	IN	O
each	each	DT	O
flavonoid	flavonoid	JJ	O
pair	pair	NN	O
.	.	.	O

In	in	IN	O
a	a	DT	O
similar	similar	JJ	O
study	study	NN	O
,	,	,	O
Li	Li	NNP	O
etÂ	etÂ	NNP	O
al	al	NNP	O
.	.	.	B
evaluated	evaluate	VBD	O
the	the	DT	O
effect	effect	NN	O
of	of	IN	O
a	a	DT	O
glucoside	glucoside	NN	O
substituent	substituent	NN	O
in	in	IN	O
position	position	NN	O
3	3	CD	O
of	of	IN	O
the	the	DT	O
C	C	NNP	O
ring	ring	NN	O
of	of	IN	O
quercetin	quercetin	NN	O
,	,	,	O
analysing	analyse	VBG	O
quercetin	quercetin	NN	O
,	,	,	O
isoquercetin	isoquercetin	NN	O
and	and	CC	O
rutin	rutin	NN	O
.	.	.	O

They	-PRON-	PRP	O
observed	observe	VBD	O
that	that	DT	O
rutin	rutin	NN	O
,	,	,	O
which	which	WDT	O
possesses	possess	VBZ	O
a	a	DT	O
disaccharide	disaccharide	NN	O
moiety	moiety	NN	O
,	,	,	O
was	be	VBD	O
the	the	DT	O
best	good	JJS	O
pancreatic	pancreatic	JJ	O
lipase	lipase	NN	O
inhibitor	inhibitor	NN	O
,	,	,	O
followed	follow	VBN	O
by	by	IN	O
isoquercetin	isoquercetin	NNP	O
monosaccharide	monosaccharide	NNP	O
moiety	moiety	NN	O
and	and	CC	O
finally	finally	RB	O
quercetin	quercetin	VB	O
aglycone	aglycone	NN	O
.	.	.	O

Those	those	DT	O
authors	author	NNS	O
found	find	VBD	O
that	that	IN	O
the	the	DT	O
placement	placement	NN	O
of	of	IN	O
a	a	DT	O
double	double	JJ	O
glycosylation	glycosylation	NN	O
of	of	IN	O
rutinoside	rutinoside	NN	O
for	for	IN	O
rutin	rutin	NN	O
,	,	,	O
provided	provide	VBD	O
a	a	DT	O
higher	high	JJR	O
possibility	possibility	NN	O
to	to	TO	O
interact	interact	VB	O
with	with	IN	O
the	the	DT	O
enzyme	enzyme	NNS	O
by	by	IN	O
increasing	increase	VBG	O
the	the	DT	O
polarity	polarity	NN	O
of	of	IN	O
the	the	DT	O
pancreatic	pancreatic	JJ	O
lipaseâprotein	lipaseâprotein	NNP	O
adduct	adduct	NN	O
,	,	,	O
by	by	IN	O
hydrogen	hydrogen	NN	O
bonding	bonding	NN	O
formation	formation	NN	O
,	,	,	O
and	and	CC	O
by	by	IN	O
decreasing	decrease	VBG	O
the	the	DT	O
hydrophobic	hydrophobic	JJ	O
environment	environment	NN	O
near	near	IN	O
the	the	DT	O
catalytic	catalytic	JJ	O
site	site	NN	O
,	,	,	O
necessary	necessary	JJ	O
to	to	TO	O
hydrolyse	hydrolyse	VB	O
the	the	DT	O
triacylglycerols	triacylglycerol	NNS	O
.	.	.	O

Matricaria	Matricaria	NNP	O
chamomilla	chamomilla	NN	O
L.	L.	NNP	O
is	be	VBZ	O
considered	consider	VBN	O
a	a	DT	O
good	good	JJ	O
source	source	NN	O
of	of	IN	O
functional	functional	JJ	O
polyphenolic	polyphenolic	JJ	O
compounds	compound	NNS	O
and	and	CC	O
the	the	DT	O
enzymatic	enzymatic	JJ	O
treatment	treatment	NN	O
of	of	IN	O
flavonoids	flavonoid	NNS	O
is	be	VBZ	O
known	know	VBN	O
to	to	TO	O
improve	improve	VB	O
bioactivity	bioactivity	NN	O
of	of	IN	O
such	such	JJ	O
compounds	compound	NNS	O
due	due	JJ	O
to	to	IN	O
removal	removal	NN	O
of	of	IN	O
sugar	sugar	NN	O
molecules	molecule	NNS	O
.	.	.	O

In	in	IN	O
this	this	DT	O
study	study	NN	O
,	,	,	O
we	-PRON-	PRP	O
observed	observe	VBD	O
that	that	IN	O
around	around	RB	O
30	30	CD	O
putatively	putatively	RB	O
identified	identify	VBN	O
compounds	compound	NNS	O
were	be	VBD	O
modified	modify	VBN	O
after	after	IN	O
treatment	treatment	NN	O
of	of	IN	O
chamomile	chamomile	NN	O
infusion	infusion	NN	O
with	with	IN	O
hesperidinase	hesperidinase	NN	O
and	and	CC	O
Î²-galactosidase	î²-galactosidase	NN	O
.	.	.	O

The	the	DT	O
infusion	infusion	NN	O
showed	show	VBD	O
interesting	interesting	JJ	O
results	result	NNS	O
for	for	IN	O
the	the	DT	O
inhibition	inhibition	NN	O
of	of	IN	O
digestive	digestive	JJ	O
enzymes	enzyme	NNS	O
,	,	,	O
mainly	mainly	RB	O
on	on	IN	O
pancreatic	pancreatic	JJ	O
lipase	lipase	NN	O
.	.	.	O

Thus	thus	RB	O
,	,	,	O
the	the	DT	O
enzymatic	enzymatic	JJ	O
treatment	treatment	NN	O
of	of	IN	O
polyphenols	polyphenol	NNS	O
can	can	MD	O
lead	lead	VB	O
to	to	IN	O
bioactivity	bioactivity	NN	O
enhancement	enhancement	NN	O
,	,	,	O
showing	show	VBG	O
the	the	DT	O
good	good	JJ	O
potential	potential	NN	O
of	of	IN	O
the	the	DT	O
enzymatically	enzymatically	RB	O
modified	modify	VBN	O
chamomile	chamomile	NN	O
infusion	infusion	NN	O
as	as	IN	O
a	a	DT	O
functional	functional	JJ	O
food	food	NN	O
for	for	IN	O
human	human	JJ	O
health	health	NN	O
benefits	benefit	NNS	O
.	.	.	O

